Category Archives: Sector Restrictions / 分行业限制

Wholly Foreign-Owned Hospitals in China: The Nine-City Pilot, the Medical Institution Licence and What Stays Closed

  • The permission to set up a Wholly Foreign-Owned Hospital rests on a notice of 7 September 2024 issued by the Ministry of Commerce, the National Health Commission and the National Medical Products Administration, not on any rule issued in 2026.
    允许设立外商独资医院的依据,是商务部、国家卫生健康委、国家药监局 2024 年 9 月 7 日印发的试点通知,而不是 2026 年出台的任何新规。
  • The Nine-City Pilot covers Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and the whole of Hainan Island.
    九地试点包括北京、天津、上海、南京、苏州、福州、广州、深圳和海南全岛。
  • Traditional Chinese Medicine is excluded from the pilot and public hospitals may not be acquired; those are the two hard boundaries of the permission.
    中医类不在试点范围内,也不含并购公立医院——这是这项许可的两条硬边界。
  • The operational plan for the wholly foreign-owned hospital pilot took effect in April 2025 and fixes the pilot areas, access conditions and scope of business a project must satisfy.
    独资医院领域扩大开放试点工作方案于 2025 年 4 月施行,确定了试点地区、准入条件和经营范围等具体要求。
  • A wholly foreign-owned hospital is a medical institution rather than an ordinary foreign-invested company: it needs pre-establishment approval and then a Medical Institution Licence before it can treat a patient.
    外商独资医院是医疗机构,不是普通外商投资企业:须先取得设置批准,再取得《医疗机构执业许可证》,才能接诊。
  • On 22 October 2026 the Ministry of Commerce said it would deepen the opening pilot in wholly foreign-owned hospitals; that is a statement of direction, it adds no city to the list, and any expansion depends on a formal document.
    2026 年 10 月 22 日商务部表示将深化独资医院等领域开放试点;这是方向性表述,并未新增试点地区,是否扩围取决于正式文件。
  • Foreign doctors need their own Practising Registration and imported devices and medicines need registration or filing with the national drug regulator; a hospital licence covers neither.
    外籍医师须另行办理执业注册,进口医疗器械与药品须取得国家药监部门注册或备案;医院执业许可不覆盖这两项。

Wholly Foreign-Owned Hospitals in China: The Nine-City Pilot, the Medical Institution Licence and What Stays Closed | 外商独资医院扩大试点:九地名单、执业许可与尚未开放的部分

Overview

A foreign hospital group looking at China meets two documents, and the order in which it reads them decides whether the project is viable. The first is the negative list for foreign investment, which still treats medical institutions as a restricted sector. The second is the notice of 7 September 2024 issued by the Ministry of Commerce, the National Health Commission and the National Medical Products Administration, which permits wholly foreign-owned hospitals in nine places: Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and the whole of Hainan Island.

In April 2025 the operational plan for the wholly foreign-owned hospital pilot took effect, setting out pilot areas, access conditions and scope of business in working detail. That plan, rather than the 2024 notice, is what a project team should read line by line.

Nothing changed in October 2026. At a State Council Information Office briefing on 22 October 2026, Wu Di of the Ministry of Commerce’s foreign investment administration said the ministry would deepen the opening pilots in cloud computing, biotechnology and wholly foreign-owned hospitals to release service-sector investment potential. That is a statement of direction. It adds no city to the list, and any expansion will arrive through a formal document. On ministry data, services took more than 70 per cent of China’s total actual use of foreign capital in 2025, which is why the sector keeps appearing in opening statements.

What the pilot permits

The permission is narrow. A wholly foreign-owned hospital may be established in one of the nine places to provide medical services other than those in the Traditional Chinese Medicine category, and it must satisfy the access conditions in the operational plan — conditions that run to the investor, the site, the bed scale, the departments and the staffing.

Two features of the design are easy to miss. The permission is place-specific: outside the nine places the negative list position is unchanged, so a group cannot take a licence granted in Shanghai and open a branch in Chengdu on the strength of it. And the permission is for establishment rather than unrestricted operation: the hospital still needs every ordinary licence a medical institution needs, plus the equipment and drug approvals described below.

The scope of business deserves early attention because it drives the investment case: a general hospital, a specialty hospital and a surgical centre meet different requirements on departments, beds and personnel, and provincial rules may add local conditions. Written confirmation of the intended scope, obtained before the feasibility study is signed off, is cheaper than discovering the mismatch at registration.

The two hard boundaries

Traditional Chinese Medicine is excluded. The exclusion is drawn at the level of the TCM category. A project that intends to offer acupuncture, tuina or herbal consultation alongside Western medicine should ask the provincial health commission how the exclusion applies to specific service lines, rather than assume that a TCM department inside a Western-medicine hospital sits outside the rule.

Public hospitals may not be acquired. The boundary is drawn at public hospitals specifically. Greenfield construction is the route the pilot contemplates. Other forms of participation in existing non-public facilities are governed by the operational plan and by provincial rules, and should be put to the authorities as a question rather than treated as settled.

The pilot is in any case an opening inside a restricted sector, not the removal of the restriction, and documents drafted for headquarters should say so.

From setting approval to a licence to practise

A wholly foreign-owned hospital is a medical institution, not an ordinary foreign-invested company, and the sequence reflects that.

The first step is pre-establishment approval — the setting approval required by the regulation on the administration of medical institutions. The application goes to the health authority at the level the operational plan specifies, in practice the provincial level, and carries the substance of the project: a feasibility study, site and floor plans, proposed beds, departments and staffing, funding evidence and the foreign investor’s own qualifications.

The second step is registration, which produces the Medical Institution Licence. The licence records the name, address, legal representative, principal person in charge, permitted diagnostic and treatment subjects and bed count. Treating patients before that licence issues is not a scheduling problem to be managed; it is practice without a licence.

The third step is corporate. The investor’s company is registered under the foreign investment law and files the foreign investment information report. The hospital licence and the company registration are separate instruments held by different authorities, and neither substitutes for the other.

Alongside these sit the permits that follow the building and the equipment: configuration approval for large medical equipment, radiation diagnosis and treatment permits, and environmental and fire acceptance. Together they set the critical path.

Three misconceptions

That wholly-owned means free pricing and free hiring. Non-public medical institutions set service prices under market adjustment rather than government guidance, but a hospital seeking medical insurance designation accepts the payment standards, price publicity and cost-control rules that come with it, and foreign doctors still need their own practising registration. Ownership displaces neither constraint.

That a public hospital can be bought. It cannot, under this pilot; a transaction structured as an acquisition of a public facility will not be approved on the strength of the 2024 notice.

That the model replicates nationally. The permission is confined to the nine places. A multi-city plan needs a multi-city legal analysis, and in most cities the answer today remains a joint venture.

People, devices, medicines and payment

Foreign doctors practising in China need registration of their own. Short-term practice requires a foreign physician short-term practice permit, valid for no more than one year; longer practice requires a Chinese physician qualification and registration. One regional variation is worth knowing: under the trade facilitation measures announced on 29 October 2026 for the Hainan Free Trade Port, the validity of the practising permit for foreign physicians in Hainan extends from one year to three. That is a Hainan-specific arrangement, and it matters when staffing costs for a Hainan site are modelled.

Imported medical devices need registration or filing with the National Medical Products Administration, and large equipment needs configuration approval before installation. Imported medicines need their own registration; the channels for clinically urgent, small-quantity imports are arrangements for specific areas and are not part of this pilot.

On payment, medical insurance designation is applied for locally and is not automatic. Most wholly foreign-owned hospitals in the pilot will run a mixed model: self-pay and commercial insurance direct billing for the core business, designation where local rules and the case allow it.

Research involving human genetic resources requires separate approval for collection, preservation and international cooperation.

Practical steps

  • Choose the city first, then read that city’s implementing rules. The nine places do not implement identically.
  • Open a pre-application channel with the provincial health commission and obtain written confirmation of the intended scope, bed scale and department list.
  • Have the foreign investor’s qualification documents notarised and authenticated, with Chinese translations in the format the receiving authority expects.
  • Sequence device registrations and physician registrations against the planned opening date; registration timelines, not construction, usually set the critical path.
  • Confirm with the commerce department that the project falls inside the pilot, and keep that confirmation with the file supporting the foreign investment information report.
  • Discuss insurance designation with the local medical insurance bureau early, because the answer shapes the revenue model rather than merely the billing process.

Outlook

The direction of travel is towards more service-sector opening, and hospitals are named in that direction. The operative question is not what the next statement will say but which document grants the permission and where it applies. Until a formal expansion is published, the nine places are the perimeter.

Related reading

  • *Wholly Foreign-Owned Hospital Pilot and Private Healthcare Opening* (Article 227) — the earlier framing of the pilot within private healthcare policy.
  • *Pharma and biotech opening moves from the foreign-investment action plan* (Article 405) — where the biotechnology pilot sits relative to hospitals.

Sources

  • 商务部、国家卫生健康委、国家药监局·关于在医疗领域开展扩大开放试点工作的通知(2024-09-07):https://www.mofcom.gov.cn/
  • 国务院新闻办公室·”十五五”商务高质量发展有关情况新闻发布会(2026-10-22):https://www.scio.gov.cn/live/2026/39833/index.html
  • 中国政府网·国务院政策文件库:https://www.gov.cn/
  • 国家卫生健康委员会·医疗机构管理条例及配套规章:https://www.nhc.gov.cn/
  • 国家药品监督管理局·医疗器械注册与备案管理:https://www.nmpa.gov.cn/

外商独资医院扩大试点:九地名单、执业许可与尚未开放的部分

概述

一家境外医院集团看中国市场,会遇到两份文件,而阅读顺序决定了项目是否可行。第一份是外商投资准入负面清单,其中医疗机构仍属限制类。第二份是商务部、国家卫生健康委、国家药监局 2024 年 9 月 7 日印发的试点通知,允许在北京、天津、上海、南京、苏州、福州、广州、深圳和海南全岛设立外商独资医院。

2025 年 4 月,《独资医院领域扩大开放试点工作方案》施行,把试点地区、准入条件和经营范围落到操作层面。项目团队应当逐条研读的是这份工作方案,而不是 2024 年的通知本身。

2026 年 10 月没有新变化。2026 年 10 月 22 日,在国务院新闻办公室发布会上,商务部外国投资管理司负责人吴迪表示,将深化云计算、生物技术、独资医院等领域开放试点,释放服务业引资潜力。这是方向性表述:它没有为名单增加任何一个城市,是否扩围要看正式文件。按商务部数据,2025 年服务业占全国实际使用外资总额比重超过七成,这也是服务业反复出现在开放表述中的原因。

试点允许什么

许可范围很窄。外商独资医院可以设在九地之一,提供中医类以外的医疗服务,并且必须满足工作方案中的准入条件——这些条件涉及投资主体、选址、床位规模、科室设置和人员配备。

这项设计有两点容易被忽略。其一,许可与地点绑定:九地之外,负面清单的立场没有变化,企业不能拿着一张在上海取得的许可去成都开分院。其二,这是设立环节的许可,不是无限制经营:医院仍须取得任何医疗机构都需要的全部许可,还要取得下文所述的设备与药品审批。

经营范围应当尽早确定,因为它决定投资测算:综合医院、专科医院与外科中心,在科室、床位和人员上的要求并不相同,省级规则还可能附加本地条件。在可行性研究定稿之前取得关于拟设范围的书面确认,比在登记环节才发现不匹配要便宜得多。

两条硬边界

中医类除外。 排除是在中医类这一类别层面作出的。如果项目打算在综合医疗之外提供针灸、推拿或中医门诊,应当向省级卫生健康部门询问该排除对具体诊疗科目如何适用,而不是自行推定”西医院里的中医科不受限制”。

不含并购公立医院。 边界明确划在公立医院上。试点设想的路径是新建。对现有非公立医疗机构的其他参与方式,由工作方案和省级规则调整,宜作为问题向主管部门提出,而不宜当作已有定论。

还需说明一点:试点是在限制类行业内部开的口子,不是取消限制;写给总部的材料应当把这一点写清楚。

从设置批准到执业许可

外商独资医院是医疗机构,不是普通外商投资企业,办理顺序也体现了这一点。

第一步是设置审批,即《医疗机构管理条例》体系下的设置批准。申请提交至工作方案确定的层级,实践中为省级卫生健康行政部门,材料承载的是项目的实质内容:可行性研究报告、选址与建筑设计平面图、拟设床位、科室与人员、资金证明,以及外方投资者自身的资质文件。

第二步是执业登记,产出《医疗机构执业许可证》。许可证载明名称、地址、法定代表人、主要负责人、诊疗科目和床位。在许可证下发前接诊,不是可以排期的进度问题,而是无证执业。

第三步是主体层面。投资者的公司依外商投资法登记,并报送外商投资信息报告。医院执业许可与公司登记是两份由不同机关出具的文书,彼此不能替代。

与上述三步并行的,是跟着建筑和设备走的许可:大型医用设备配置许可、放射诊疗许可,以及环保与消防验收。这些合起来决定了关键路径。

三个误区

以为”独资”等于自由定价、自由引医。 非公立医疗机构的医疗服务价格实行市场调节价,不由政府定价;但一家希望取得医保定点的医院,要接受随之而来的支付标准、价格公示和费用控制要求,外籍医师也仍须办理各自的执业注册。股权结构改变不了这两项约束。

以为可以收购公立医院。 本试点下不可以。把交易结构设计成收购公立医疗机构,不能凭 2024 年的通知获得批准。

以为模式可以全国复制。 许可限于九地。多城市布局需要多城市的法律分析,而在多数城市,目前的答案仍是合资。

人员、设备、药品与支付

外籍医师在华执业须另行办理注册。短期行医需取得外国医师短期行医许可,有效期不超过一年;长期执业须取得中国医师资格并注册。有一处地区差异值得了解:按 2026 年 10 月 29 日公布的海南自由贸易港贸易便利化措施,外籍医师在海南的执业许可有效期由一年延长至三年。这是海南特有的安排,在测算海南机构人力成本时会用到。

进口医疗器械须取得国家药品监督管理局的注册或备案,大型设备在装机前须取得配置许可。进口药品须另行注册;临床急需少量进口的通道属于特定区域的安排,不在本试点范围内。

支付方面,医保定点在属地申请,并非自动取得。试点内的外商独资医院多数会走混合模式:核心业务以自费与商业保险直付为主,在本地规则和具体条件允许时申请定点。

涉及人类遗传资源的科研,其采集、保藏和对外合作须另行取得审批。

实务动作

  • 先定城市,再读该市的实施细则。九地的执行并不一致。
  • 与省级卫生健康部门建立预沟通渠道,取得关于拟设范围、床位规模和科室清单的书面确认。
  • 外方资质文件办理公证认证,中文译本按受理机关的格式准备。
  • 把器械注册与医师注册排到计划开业日之前倒推。决定关键路径的通常是注册周期,而不是施工。
  • 向商务主管部门确认项目属于试点范围,并将该确认与支持外商投资信息报告的材料一并归档。
  • 尽早与属地医保部门沟通定点事宜,因为这个答案决定的是收入模型,而不只是结算流程。

展望

方向是服务业进一步开放,医院被写进了这个方向。对具体项目而言,真正的问题不是下一句表态会说什么,而是哪份文件授予许可、许可适用于哪里。在正式扩围文件公布之前,九地就是边界。

延伸阅读

  • 《外资独资医院试点与社会办医扩大开放》(第 227 篇)——试点在社会办医政策中的早期定位。
  • 《外资行动方案中的医药与生物技术开放举措》(第 405 篇)——生物技术试点与医院试点的相对位置。

来源

  • 商务部、国家卫生健康委、国家药监局·关于在医疗领域开展扩大开放试点工作的通知(2024-09-07):https://www.mofcom.gov.cn/
  • 国务院新闻办公室·”十五五”商务高质量发展有关情况新闻发布会(2026-10-22):https://www.scio.gov.cn/live/2026/39833/index.html
  • 中国政府网·国务院政策文件库:https://www.gov.cn/
  • 国家卫生健康委员会·医疗机构管理条例及配套规章:https://www.nhc.gov.cn/
  • 国家药品监督管理局·医疗器械注册与备案管理:https://www.nmpa.gov.cn/

Foreign Investment in Chinese Agriculture and Seed Breeding: Where the Negative List Still Bites, and Why Contractual Control Does Not Cure It

  • China’s Special Administrative Measures for Foreign Investment Access still list rare and unique precious improved varieties — and the propagating material produced from them — as a restricted activity, while processing, machinery and farm services sit outside the list.
    中国现行外商投资准入特别管理措施仍将稀有和特有的珍贵优良品种及其繁殖材料的生产列为限制类活动,而农产品加工、农业机械与农业技术服务不在清单之内。
  • A seed business needs a seed production and operation licence before any question of shareholding arises, so the licensing authority examines the applicant’s actual foreign status rather than the name on the holding company.
    种业经营须先取得种子生产经营许可证,股权结构问题在其后才出现;发证机关审查的是申请人的实际外资身份,而不是控股公司的名称。
  • Contractual control does not change the identity of the foreign investor, does not convert a domestic licence holder into a domestic-controlled entity, and does not remove the form-of-investment requirement in the negative list.
    协议控制不改变外资身份,不使持证的境内主体变成内资控股,也不消除负面清单对投资形式的要求。
  • The arrangement suits an asset-light service business where the licence is not the regulated asset; it fails where the licence itself is what the access rule protects.
    该安排适用于许可证本身不是受监管资产的轻资产服务业务;当准入规则保护的正是许可证时,它不成立。
  • Genetically modified seed work runs on a second track: a biosafety certificate is required before a modified variety can be approved or registered, and the certificate is a precondition for the seed licence as well.
    转基因种子研发另走一条轨道:品种须先取得安全证书才能审定或登记,安全证书同时是取得种子许可证的前提。
  • Layered structures also create tax and foreign exchange exposure, because a licence holder controlled by contract remains a Chinese taxpayer and every outbound payment still needs a genuine transaction basis.
    多层架构还带来税务与外汇敞口:以合同控制的持证主体仍是中国纳税人,每一笔对外支付仍需真实交易基础。
  • The workable sequence is to fix variety provenance, quarantine and biosafety documentation and pre-communication with the provincial agriculture department before the equity chain is designed.
    可行的顺序是先落实品种来源、检疫与生物安全文件以及与省级农业农村部门的前置沟通,再设计股权链条。

Foreign Investment in Chinese Agriculture and Seed Breeding: Where the Negative List Still Bites, and Why Contractual Control Does Not Cure It | 外资进入中国农业与种业:负面清单剩余限制在哪里,协议控制为何解决不了准入

Overview

Foreign investment in Chinese agriculture raises two questions that are usually answered in the wrong order. The first is whether the activity appears in the Special Administrative Measures for Foreign Investment Access — the negative list — and, if so, in what corporate form it may be carried on. The second is whether it needs a licence under the Seed Law, and who may hold that licence.

The current list has been in force since 1 November 2024 and cleared the manufacturing entries; what remains in agriculture is narrow but not empty. Two parallel lists sit alongside it, for pilot free trade zones and for Hainan Free Trade Port; a project inside a zone is tested against the zone’s list, where the difference is usually which entries are suspended.

What the list still restricts

The surviving agriculture entry concerns China’s rare and unique precious improved varieties: research and development, breeding and cultivation, and the production of related propagating material, with the official wording also referring to improved genes in the crop, livestock and aquaculture sectors. The entry is not about farming in general. It is about genetic material China treats as a national asset — varieties that exist here and nowhere else, and the propagation stock derived from them.

Because the entry is drafted around the variety rather than the crop, the compliance question is always the same: does this variety, or this batch of propagating material, fall inside the description? Growing commodity maize for the domestic feed market is ordinary production; seeking access to a protected local landrace to build a breeding pipeline is the regulated core.

Where the entry applies, the list imposes a requirement on the form of investment. In practice a wholly foreign-owned operating company is not the vehicle, and the project proceeds through a joint venture or a cooperative arrangement with a Chinese party. The constraint attaches to the vehicle, not to the profitability or scale of the activity.

Three lanes that are open

Most of the value chain sits outside the list: the sector is often described as closed when only one link in it is.

Processing and distribution. Food and feed processing is manufacturing, and the manufacturing entries have been cleared. A group may own a plant, a cold chain, a flour mill or a feed mill outright, subject to the ordinary establishment regime and to product standards. Wholesale, retail and cross-border e-commerce are also outside the list.

Machinery and equipment. Agricultural machinery, irrigation equipment, greenhouse systems and the software that runs them are manufacturing and services, not restricted agriculture.

Technical services. Agronomy advisory, soil and water testing, farm management software and irrigation design are outside the list. Two overlays remain: testing bodies need accreditation before issuing reports that regulators accept, and services in a regulated category — pesticide advice, veterinary diagnosis — carry their own professional requirements.

Licensing comes before shareholding

For a seed business the sequence matters more than the structure. The Seed Law, as revised with effect from 1 March 2022, works through a single seed production and operation licence — the former separate production and operation licences were merged some years ago — and the applicant must show facilities, equipment and technical personnel appropriate to the category, and lawful provenance of the variety: an owned variety right, an authorisation from the right holder, or a documented breeding source.

Three further gates sit above the licence, and projects fail at them more often than on the equity question. Major crop varieties must pass national or provincial approval before promotion, and varieties of non-major crops on the registration catalogue must be registered. Seed and propagating material brought from abroad requires plant quarantine approval, and the phytosanitary status of the consignment is examined on entry. Genetically modified material runs on a separate track: a biosafety certificate is required before a modified variety can be approved or registered, and the certificate is a precondition for the seed licence as well.

The licence is therefore issued to an applicant whose ownership the authority can see.

Why contractual control does not cure the access problem

The contractual control structure was built for a different problem: a domestic operating company holds a licence that a foreign-owned company could not hold, and the foreign investor reaches the licence holder’s economics through contracts — exclusive service fees, equity pledges, voting proxies, call options — rather than through registered equity.

In a sector where the restriction is on corporate form, that arrangement is sometimes tolerated. In seed breeding it does not work, for two compounding reasons.

The authority reviews the applicant, not the chart. The licence is granted after an examination of the applicant’s facilities, personnel and variety provenance, and the applicant’s actual controller is part of that examination. A company whose registered shareholders are Chinese nationals but whose decisions, cash flow and technology run to an offshore parent presents a factual question the authority may test. If the arrangement is treated as a device to circumvent the access rule, the licence is exposed to revocation and the parties to administrative penalties.

The contractual layer creates no lawful capital account route. Dividends require equity. Without equity, value leaves as service fees, royalties or purchase payments — each needing a genuine transaction, an arm’s-length price and invoicing, and, for payments abroad, withholding tax treatment plus a transfer pricing file where the payee is related. The cost is priced in downstream too: borrowing against the business, a group treasury arrangement or a portfolio transfer all require a clean equity chain.

Contractual control is a financing technique for asset-light, licence-free service businesses. Where the licence itself is the regulated asset — seeds, propagating material, GMO events — the structure does not reach the licence at all.

Practical steps

Work in this order; each step assumes the previous one is closed.

  1. Characterise the variety in writing. A legal opinion or internal memorandum naming the variety, the propagating material and the intended activity, and stating whether each falls within the entry — before the term sheet, not after.
  2. Fix provenance of the variety right. A variety right certificate, an exclusive licence recorded with the competent authority, or a documented breeding record. An unrecorded assignment from a research institute is a common defect.
  3. Assemble the quarantine and biosafety file. Introduction approval, phytosanitary certificates and, for modified material, the safety certificate at the applicable stage.
  4. Pre-communicate with the provincial agriculture department. Practice differs by province on personnel thresholds and on-site inspection; a pre-application meeting prevents a rejection cycle.
  5. Then design the equity chain — confirming whether a joint venture or cooperative form is required, and whether the Chinese partner must hold the variety right or the production site.
  6. File the foreign investment information report through the commerce system, separately from the licence and from market entity registration.
  7. Map the tax and foreign exchange consequences — royalty withholding, service fee pricing, and the capital account route for any future dividend.

Outlook

The direction of the negative list has been one-way for a decade: entries are removed and rarely added. Agriculture has moved slowest, and the reason is not commercial. The retained entry protects genetic material, which is treated as a resource over which the state asserts sovereignty; the rules on providing germplasm abroad rest on that premise. Separating the variety from the breeding activity is technically conceivable but has not been proposed.

More likely in the near term is zone-level experimentation — pilot arrangements around germplasm introduction and transit, such as Hainan’s germplasm transit facility. A group with a breeding pipeline should plan on the national entry staying, with access obtained through a Chinese partner holding the licence, a licence-in arrangement, or a zone pilot.

Related reading

  • *China’s Three Negative Lists for Services Opening: What the 22 October 2026 Briefing Confirmed* (Article 479) — how the national, free trade zone and Hainan lists differ.

Sources

  • National Development and Reform Commission — Special Administrative Measures for Foreign Investment Access (negative list): https://www.ndrc.gov.cn/
  • Ministry of Commerce — foreign investment reporting and access administration: https://www.mofcom.gov.cn/
  • Ministry of Agriculture and Rural Affairs — seed production and operation licensing, variety approval and registration: https://www.moa.gov.cn/
  • The State Council of China — policy document library: https://www.gov.cn/
  • State Administration for Market Regulation — registration of foreign-invested enterprises: https://www.samr.gov.cn/

外资进入中国农业与种业:负面清单剩余限制在哪里,协议控制为何解决不了准入

概述

外资进入中国农业,会引出两个常被颠倒顺序回答的问题。第一个:这项活动是否列入《外商投资准入特别管理措施(负面清单)》,如果列入,应以何种企业形式经营。第二个:这项活动是否需要依《种子法》取得许可,谁有资格持有该许可。

现行清单自 2024 年 11 月 1 日起施行,制造业条目已经清零;农业领域保留的条目范围很窄,但并非空白。与全国清单并行还有自贸试验区与海南自由贸易港两张清单;项目落在园区内的,应对照园区清单判断,差别通常在于哪些条目被暂停适用。

清单还限制什么

保留的农业条目指向中国稀有和特有的珍贵优良品种:研发、养殖、种植,以及相关繁殖材料的生产,官方表述同时括注涉及种植业、畜牧业、水产业的优良基因。这一条目管的不是一般意义上的种地,而是中国视为国家资产的遗传材料——只存在于中国、别处没有的品种,以及由这些品种繁育出的繁殖材料。

由于条目按”品种”而非”作物”起草,实际项目中的合规问题永远是同一个:这个具体品种、这批具体繁殖材料,是否落在条目的描述之内。为国内饲料市场种植商品玉米属于普通生产;为搭建育种管线而获取某一受保护地方品种,才是受监管的核心。

条目适用的,清单对投资形式设有要求。实务中这意味着外商独资的经营公司不是合适的载体,项目通常以与中国一方合资或合作的方式推进。约束落在载体上,不落在项目的盈利性或规模上。

三条开放通道

价值链的大部分不在清单之内:这个行业常被描述成”关闭”,而关闭的只是其中一环。

加工与流通。 食品与饲料加工属于制造业,制造业条目已经清零。集团可以独资持有加工厂、冷链、面粉厂或饲料厂,适用一般设立制度与产品标准。批发、零售、跨境电商同样不在清单之内。

机械与设备。 农业机械、灌溉设备、温室系统,以及运行这些设备的软件,属于制造业与服务业,不属于受限农业。

技术服务。 农艺咨询、土壤与水质检测、农场管理软件、灌溉设计都不在清单之内。仍有两层叠加要求:检验检测机构在出具监管机关认可的报告前须取得资质认定;农药用药指导、兽医诊断这类受监管服务另有各自的专业资质要求。

许可在前,股权在后

对种业而言,顺序比结构更重要。《种子法》自 2022 年 3 月 1 日起施行的修订,沿用”两证合一”的种子生产经营许可证(原生产许可证与经营许可证已于数年前合并)。申请人须证明具备与所申请类别相适应的设施、设备与技术人员,并证明品种来源合法:自有品种权、品种权人的授权,或有据可查的育种来源。

许可证之上还有三道关口,项目在关口上失败的概率高于在股权问题上失败。主要农作物品种须经国家级或省级审定后方可推广,列入登记目录的非主要农作物品种须办理登记;从境外引进种子与繁殖材料须办理植物检疫审批,进境时查验植物检疫状况;转基因材料另走一条轨道,须先取得安全证书才能审定或登记,安全证书同时是取得种子许可证的前提。

许可证因此发给的是一个所有权能被审查机关看清的申请人。

协议控制为何解决不了准入

协议控制架构本来是为另一个问题设计的:境内经营公司持有一张外资公司无法持有的许可证,境外投资人通过一组合同——独家服务费、股权质押、表决权委托、买入选择权——取得持证主体的经济利益,而不是通过登记股权。

在限制落在”企业形式”上的行业,这种安排有时被容忍。在种业,它不成立,原因有二,且相互叠加。

审查机关审的是申请人,不是架构图。 许可证在审查申请人的设施、人员与品种来源之后核发,申请人的实际控制人属于审查内容。一家登记股东为中国籍自然人、但决策、现金流与技术全部指向境外母公司的公司,呈现的是一个审查机关有权核查的事实问题。若该安排被认定为规避准入的工具,许可证面临被撤销的风险,相关方亦面临行政处罚。

合同层不产生合法的资本项目通道。 分红需要股权。没有股权,价值只能以服务费、特许权使用费或采购款的形式流出——每一项都需要真实交易、公允价格与发票;向境外支付的,还需要预提所得税处理,收款方为关联方的另需转让定价文档。结构的成本还会传导到下游:以种业资产举债、并入集团资金池、转让品种组合,都要求股权链条干净。

协议控制是一种适用于轻资产、无需持证的服务类业务的融资技术。当许可证本身就是受监管的资产时——种子、繁殖材料、转基因事件——这个结构根本触不到许可证。

实操步骤

按下面的顺序推进,每一步都以前一步已完成为前提。

  1. 把品种定性写下来。 用法律意见或内部备忘写明品种、繁殖材料与拟从事的活动,并逐项说明是否落入条目——在条款清单之前完成,而不是之后。
  2. 落实品种权来源。 植物新品种权证书、在主管机关备案的独占许可,或有据可查的育种记录。来自科研院所但未办理备案的转让,是常见瑕疵。
  3. 备齐检疫与生物安全文件。 引进审批、植物检疫证书,转基因材料还需相应阶段的安全证书。
  4. 与省级农业农村部门前置沟通。 各省在人员门槛与现场核查上做法不同;一次预沟通可以避免一轮退回。
  5. 再设计股权链条——确认是否要求合资或合作形式,中方合作方是否须持有品种权或生产基地。
  6. 办理外商投资信息报告。 通过商务系统报送,与许可证和市场主体登记分开。
  7. 梳理税务与外汇后果——特许权使用费预提税、服务费定价,以及未来分红所需的资本项目路径。

展望

十年来负面清单的方向是单向的:条目被删除,极少被新增。农业移动最慢,原因不在商业层面。保留的条目保护的是遗传材料,而遗传材料被视为国家主张主权的资源;向境外提供种质资源的规则正建立在这一前提之上。把品种与育种活动分开处理的放开思路在技术上可行,但目前没有被提出。

近期更可能出现的是园区层面的试验——围绕种质资源引进与中转的试点安排,类似海南的种质资源中转设施。拥有育种管线的集团,现实规划假设应是:全国条目维持不变,准入通过持有许可证的中方合作方、许可引进安排,或园区试点取得。

延伸阅读

  • 《中国服务业开放的三张负面清单:2026 年 10 月 22 日发布会确认了什么》(第 479 篇)——全国、自贸试验区与海南三张清单的区别。

来源

  • 国家发展和改革委员会·外商投资准入特别管理措施(负面清单)发布与解读:https://www.ndrc.gov.cn/
  • 商务部·外商投资信息报告与外资准入管理:https://www.mofcom.gov.cn/
  • 农业农村部·种子生产经营许可、品种审定与登记:https://www.moa.gov.cn/
  • 中国政府网·政策文件库:https://www.gov.cn/
  • 国家市场监督管理总局·外商投资企业登记注册:https://www.samr.gov.cn/

China’s Three Negative Lists for Services Opening: What the 22 October 2026 Briefing Confirmed

  • At the 22 October 2026 State Council Information Office briefing, the Ministry of Commerce named three negative lists — foreign investment access, cross-border trade in services, and cross-border data flow — as the handle for expanding voluntary opening in priority sectors.
    在 2026 年 10 月 22 日国务院新闻办公室发布会上,商务部把外商投资准入、跨境服务贸易、数据跨境流动三张负面清单确定为扩大重点领域自主开放的抓手。
  • The three lists answer three different questions: whether a foreign investor may hold equity, whether a service may be delivered across the border without an establishment, and whether data may leave the territory.
    三张清单回答三个不同的问题:外资能否持股、服务能否不设机构跨境交付、数据能否出境。
  • China now has 23 pilot free trade zones after Inner Mongolia was added in April 2026; nine zones plus the Hainan Free Trade Port have issued data export negative lists covering 28 industry fields.
    2026 年 4 月新设内蒙古自贸试验区后,自贸试验区总数达 23 个;北京、上海、广东等 9 个自贸试验区和海南自由贸易港已发布数据出境负面清单,涵盖 28 个行业领域。
  • In January–August 2026 the 23 pilot zones recorded RMB 8 trillion in imports and exports and RMB 128.74 billion in utilised foreign investment, up 36.7% and 19.3% year on year, or 23.1% and 26.8% of the national totals.
    2026 年 1—8 月,23 个自贸试验区进出口总额 8 万亿元、实际使用外资 1 287.4 亿元,同比分别增长 36.7% 和 19.3%,占全国的 23.1% 和 26.8%。
  • Utilised foreign investment fell 4.3% year on year in January–September, a narrowing of 6.1 percentage points from the same period last year, while high-tech sectors rose 33.8% and reached 41.6% of the total.
    1—9 月全国实际使用外资同比下降 4.3%,降幅较去年同期收窄 6.1 个百分点;高技术产业引资增长 33.8%,占比 41.6%。
  • The next opening steps named were pilots in cloud computing, biotechnology and wholly foreign-owned hospitals, support for more qualified offshore issuers of panda bonds, and national treatment in government procurement, tendering and standard-setting.
    下一步开放举措包括云计算、生物技术、独资医院等领域试点,支持更多符合条件的境外主体在华发行熊猫债,以及在政府采购、招投标、标准制定中落实国民待遇。
  • The 29-measure national services list and 27-measure pilot-zone list are an existing public position from June 2026, not an October measure; the NDRC’s talk of a timely reduction is a press account and no revised list has been issued.
    服务业全国版 29 条、自贸试验区版 27 条是 2026 年 6 月的既有公开口径,不是 10 月新政;国家发展改革委关于”适时缩减”的表述属报道口径,修订清单尚未出台。

China’s Three Negative Lists for Services Opening: What the 22 October 2026 Briefing Confirmed | 中国服务业开放的三张负面清单:2026 年 10 月 22 日发布会确认了什么

Overview

On 22 October 2026 the State Council Information Office held a briefing in its “opening the 15th Five-Year Plan” series on high-quality development of commerce during the period. Vice Minister of Commerce Jiang Chenghua attended, together with Wu Di of the department of foreign investment administration, Yang Tao of the department of foreign trade, and Yang Mu of the department of market operation and consumption promotion.

Wu Di’s answers are the part that matters for foreign investors. The next stage of pilot free trade zone work, he said, will take three negative lists as its handle — foreign investment access, cross-border trade in services, and cross-border data flow — to expand voluntary opening in priority fields. Alongside them he put support for new forms of business such as cross-border e-commerce and bonded maintenance, and more active international cooperation between free trade parks.

The three lists are routinely treated as one instrument. They are not: each answers a different question, is issued by a different authority, and is consulted at a different point in a project.

Three lists, three different questions

Foreign investment access negative list — may a foreign investor hold equity here at all. This list decides whether a sector is open, restricted (a Chinese partner required, or a cap on the foreign share), or prohibited. It governs establishment and equity acquisition, and it is what a company checks before drafting a joint venture or a wholly foreign-owned structure. According to the Ministry of Commerce’s briefing of 22 June 2026 — an existing public position, not an October measure — restrictions in manufacturing had been reduced to zero, while the services list carried 29 measures in the national version and 27 in the pilot-zone version.

Cross-border trade in services negative list — may the service be delivered across the border without a commercial presence. This list governs supply from outside the territory: a design studio serving Chinese clients from abroad, a remote data-processing service, a foreign institution delivering courses online. A business can sit entirely outside the foreign investment access list and still meet this one, because no entity is being established. The two lists therefore have to be read together for any service that is delivered remotely but also sold through a local presence.

Cross-border data flow negative list — may the data leave. Issued by pilot free trade zones and by the Hainan Free Trade Port, these lists describe by industry and by data category what may be transferred abroad. Under the current data export regime, transfers that fall outside the applicable local list are relieved of the security assessment, the standard contract filing and the certification route. Wu Di said nine pilot zones — Beijing, Shanghai, Guangdong among them — together with the Hainan Free Trade Port had issued such lists, covering 28 industry fields.

Two consequences follow. The relief is procedural, not substantive: the Personal Information Protection Law, the Data Security Law and sectoral rules continue to apply, so a transfer outside the list must still be lawful on its own terms. And the lists are local, so a group with operations in several provinces may face several different answers for the same data set.

What the briefing added on the zones themselves

Inner Mongolia’s pilot zone was established in April 2026, bringing the total to 23. In the zone’s first half year of operation, from April to September, the two hub ports at Manzhouli and Erenhot handled 5,719 China–Europe freight trains between them, 17.5% more than a year earlier.

The Ministry of Commerce and the State Administration for Market Regulation have also supported four pilot zones, including Hebei, and the Hainan Free Trade Port in a first batch of standardised voluntary opening pilots — an effort to make opening measures comparable and repeatable rather than zone-specific.

Wu Di set the work under three headings: strengthening the zones’ function as a source of reform and innovation to lead new quality productive forces; expanding high-level voluntary opening to lead deeper international economic and commercial cooperation, which is where the three lists sit; and serving major national strategies, through cross-regional coordination among the zones of the Beijing–Tianjin–Hebei region, the Yangtze River Delta, the Yangtze River Economic Belt and the Yellow River basin, and replication of reform results nationwide or in specific regions.

The numbers presented

Utilised foreign investment in January–September 2026 fell 4.3% year on year, a narrowing of 6.1 percentage points compared with the same period of 2025. High-tech sectors attracted 33.8% more and accounted for 41.6% of the total. Reinvested profits reached RMB 93.99 billion in the nine months, up 4.7%, with their share 1.5 percentage points higher than a year earlier. Within high-tech, R&D and design services rose 59.2%, energy-saving and environmental-protection industries 11.1%, and digital economy industries 7%.

There are more than 560,000 foreign-invested enterprises in the country. This year has added 84 key projects and 6 flagship projects, with total investment close to USD 20 billion.

For the zones, January–August figures put imports and exports at RMB 8 trillion and utilised foreign investment at RMB 128.74 billion, up 36.7% and 19.3%, or 23.1% and 26.8% of the national totals.

What comes next, and what is not yet decided

Wu Di listed the next opening steps: deepening pilots in cloud computing, biotechnology and wholly foreign-owned hospitals; advancing the national comprehensive pilot programme for opening the services sector; supporting more qualified offshore institutions to issue panda bonds onshore; fully implementing national treatment for foreign-invested enterprises, with government procurement, tendering and standard-setting treating them alike; and making the foreign enterprise roundtable more effective.

Separately, Shanghai Securities News reported on 16 October that the National Development and Reform Commission intends during the 15th Five-Year Plan period to open telecommunications, the internet, education, culture and healthcare in an orderly way and to reduce the foreign investment access negative list at an appropriate time. That is a press account of an intention. No revised list has been published, and no timetable attaches to it.

Implications for foreign companies

Sequence the three lists before committing to a structure. A service delivered remotely is a cross-border trade question first; a service sold through a local entity is an access question first; and either may then raise a data question if personal information or important data crosses the border. Treating the three as a single gate leads to the common error of clearing the access list and then discovering that the delivery model or the data flow is the binding constraint.

Use the local data list, and read it at field level. The 28 industry fields covered by the nine zones and Hainan are not a national list, and the relief they offer attaches to transfers that the list describes. A company should obtain the text of the list for the province where the exporting entity sits, map its actual transfers — fields, purpose, recipient — against it, and keep the mapping on file. Where a transfer falls inside the list, the security assessment or standard contract route still applies.

Do not build a plan on the negative list revision. The 29 and 27 figures are current, the intention to reduce them has been reported but not published, and sectors named for opening — telecommunications, the internet, education, culture, healthcare — are precisely those where a specific implementing measure, not a headline, determines whether a project can proceed.

Related reading

  • *China’s 15-Measure Action Plan for Stabilising Foreign Investment: A Clause-by-Clause Guide* (Article 471) — the action plan’s market access and facilitation items, including the data export negative list work, are analysed there.

Sources

  • 国务院新闻办公室·2026-10-22「开局起步’十五五’」系列主题新闻发布会(商务部推进「十五五」时期商务高质量发展有关情况),含发布会文字实录:http://www.scio.gov.cn/
  • 中国(河南)自由贸易试验区郑州片区·商务部出题,自贸试验区要做好「三个引领」大文章(2026-10-22),含吴迪关于三张负面清单的原话与自贸试验区数据:https://zzftz.zhengzhou.gov.cn/zmdt/10311269.jhtml
  • 中国(湖南)自由贸易试验区·吴迪答记者问实录(2026-10-23):https://ftz.hunan.gov.cn/hnzm/list01/202610/t20261023_34087161.html
  • 中华人民共和国商务部·外国投资管理司(外商投资准入负面清单、自贸试验区工作主管司局):https://www.mofcom.gov.cn/

中国服务业开放的三张负面清单:2026 年 10 月 22 日发布会确认了什么

概述

2026 年 10 月 22 日,国务院新闻办公室举行”开局起步’十五五'”系列主题新闻发布会,介绍推进”十五五”时期商务高质量发展有关情况。商务部副部长蒋成华出席,商务部外国投资管理司负责人吴迪、对外贸易司司长杨涛、市场运行和消费促进司司长杨沐一同出席。

对外资企业而言,信息量集中在吴迪的回答里。他表示,下一步自贸试验区工作将以外商投资准入、跨境服务贸易、数据跨境流动三张负面清单为抓手,扩大重点领域自主开放;同时支持跨境电商、保税维修等新业态新模式创新发展,主动加强自贸园区国际合作。

这个表述值得拆开看,因为三张清单在实践中常被当成一件工具。它们并不是。三者回答的是三个不同的问题,发布主体不同,在一笔投资的不同阶段被查阅。

三张清单回答三个不同的问题

外商投资准入负面清单:外资在这一行业能不能持股。 这张清单决定一个行业是开放、限制(须有中方合资方,或外资股比有上限)还是禁止。它管的是设立与股权取得,企业在起草合资或外商独资架构之前查阅的就是它。按商务部 2026 年 6 月 22 日发布会口径(属既有公开信息,不是 10 月的新政策),制造业领域外商投资准入负面清单的限制措施已经”清零”;服务业领域,全国版为 29 条,自贸试验区版为 27 条。

跨境服务贸易负面清单:这项服务能不能不设机构、从境外直接交付。 这张清单管的是跨境提供:境外设计机构为中国客户提供服务、境外主体远程提供数据处理服务、境外教育机构在线授课,都落在它的范围内。一家企业可以完全不触及外商投资准入清单,却撞上这一张,因为整个交易里没有任何主体设立动作。对既远程交付、又通过本地机构销售的服务,两张清单必须合起来读。

数据出境负面清单:数据能不能出去。 这类清单由自贸试验区和海南自由贸易港发布,按行业、按数据类别列明哪些数据可以传输至境外。按现行数据出境管理制度,落在本地负面清单范围之外的数据出境,可免于申报数据出境安全评估、订立个人信息出境标准合同、通过个人信息保护认证。吴迪介绍,已有北京、上海、广东等 9 个自贸试验区和海南自由贸易港制定发布数据出境负面清单,涵盖 28 个行业领域。

这一结构带来两个后果。其一,豁免是程序性的,不是实体义务的免除:《个人信息保护法》《数据安全法》以及分行业规定仍然适用,清单之外的数据出境本身仍须合法。其二,清单是地方性的,一个在多个省份有实体的集团,同一套数据可能面对几个不同答案。

发布会补充的自贸试验区情况

2026 年 4 月新设内蒙古自贸试验区,总数达 23 个。该试验区运行的首个半年,即 4 月至 9 月,满洲里、二连浩特两大综合枢纽口岸合计过境中欧班列 5 719 列,同比增长 17.5%。

商务部还将会同市场监管总局,支持河北等 4 个自贸试验区和海南自由贸易港开展首批标准化自主开放试点。这项工作的指向是让开放举措可比、可复制,而不是停留在单个试验区的个案安排上。

吴迪把工作归入”三个引领”:一是强化改革创新策源功能,引领发展新质生产力;二是扩大高水平自主开放,引领深化国际经贸合作,三张负面清单属于这一条;三是深入服务国家重大战略,包括京津冀、长三角、长江经济带、黄河流域各自贸试验区的跨区域协同联动,以及改革成果向全国或特定区域复制推广。

发布会给出的数据

2026 年 1—9 月,全国实际使用外资同比下降 4.3%,降幅较去年同期收窄 6.1 个百分点。高技术产业引资增长 33.8%,占比 41.6%。1—9 月利润再投资 939.9 亿元,同比增长 4.7%,占比较去年同期提高 1.5 个百分点。高技术产业内部,研发与设计服务业引资同比增长 59.2%,节能环保清洁产业增长 11.1%,数字经济产业增长 7%。

存量外资企业超过 56 万家。今年以来全国新增 84 个重点外资项目、6 个标志性项目,总投资近 200 亿美元。

自贸试验区方面,1—8 月 23 个自贸试验区进出口总额 8 万亿元、实际使用外资 1 287.4 亿元,同比分别增长 36.7% 和 19.3%,占全国的 23.1% 和 26.8%。23 个试验区在全国版图上占比不大,却承载了约四分之一的贸易额和外资流入。

下一步,以及尚未确定的部分

吴迪列出的下一步开放方向包括:深化云计算、生物技术、独资医院等领域开放试点;深入推进国家服务业扩大开放综合试点示范;支持更多符合条件的境外主体在华发行熊猫债;全面落实外资企业国民待遇,在政府采购、招投标、标准制定中一视同仁;放大外资企业圆桌会效能。

另据上海证券报 10 月 16 日报道,国家发展改革委表示”十五五”时期将推动电信、互联网、教育、文化、医疗等领域有序扩大开放,适时缩减外资准入负面清单。这是媒体报道的取向表述,修订后的清单尚未公布,也没有附带时间表。

对外资企业的实务意义

先给三张清单排顺序,再定架构。远程交付的服务,第一关是跨境服务贸易;通过本地实体销售的服务,第一关是准入;两者都可能再引出数据问题,如果涉及个人信息或重要数据出境。把三者当成一道门,最常见的错误是过了准入这一关,才发现真正卡住的是交付模式或数据流向。

数据清单要用本地的,并且读到字段一级。9 个自贸试验区加海南覆盖的 28 个行业领域不是一张全国清单,其提供的便利只附着于清单所描述的那些出境情形。企业应取得导出主体所在省份的清单文本,把实际发生的传输按字段、用途、接收方列出来逐项比对,并把这份比对留档。落在清单范围之内的,安全评估或标准合同路径仍然适用。

不要把方案建立在负面清单修订上。29 条和 27 条是现行口径,”适时缩减”是报道出来的取向而非已公布文本;被点到的电信、互联网、教育、文化、医疗,恰恰是具体实施办法而非标题决定项目能否推进的领域。

延伸阅读

  • 《中国利用外资固稳促优行动方案 15 条逐条解读》(第 471 篇)——行动方案中的市场准入与投资便利化条目,包括数据出境负面清单相关工作,在该文中已有分析。

来源

  • 中国(湖南)自由贸易试验区官网·吴迪答记者问实录(2026-10-23):https://ftz.hunan.gov.cn/hnzm/list01/202610/t20261023_34087161.html
  • 中央纪委国家监委网站·发布会通稿(2026-10-22):https://www.ccdi.gov.cn/yaowenn/202610/t20261022_518426.html
  • 央视网经济频道·外资布局新赛道与发布会数据(2026-10-23):https://jingji.cctv.cn/2026/10/23/ARTIKXXhnhiRiggsF0aRFJZY261023.shtml
  • 上海证券报·外商直接投资权益存量与国家发展改革委口径(2026-10-16):https://paper.cnstock.com/html/2026-10/16/content_2277771.htm

Green and Low-Carbon Provisions in the Opinion on Developing New Quality Productive Forces

  • The green and low-carbon provisions sit in the third part of the Opinion, “focusing on innovating the development model”, which calls for building a green, low-carbon and circular economic system and for advancing the energy revolution.
    绿色低碳条款位于《意见》第三方面”着力推进发展方式创新”,提出构建绿色低碳循环发展经济体系,积极推进能源革命。
  • The text calls for building a power system with a high proportion of renewable energy and for improving policies on the consumption and regulation of new energy.
    文件提出构建高比例可再生能源电力系统,完善新能源消纳和调控政策措施。
  • “Orderly development of advanced nuclear fission energy” appears alongside renewables, but nuclear power remains a sector governed by the negative list; specific access is subject to the current negative list.
    “有序发展先进核裂变能”与可再生能源并列出现,但核电仍属《外商投资准入负面清单》管理领域,具体准入以现行负面清单为准。
  • The clause adds “all-round international co-operation”, framing the energy transition as an area open to cross-border participation.
    条款包含”全方位加强国际合作”,将能源转型定位为可跨境参与的领域。
  • According to public reports, the 2025 edition of the Catalogue of Industries for Encouraging Foreign Investment contains 1,679 entries, 205 more than the 2022 edition, and takes effect on 1 February 2026.
    据公开报道,《鼓励外商投资产业目录(2025 年版)》总条目 1679 条,比 2022 年版净增 205 条,自 2026 年 2 月 1 日施行。
  • Per public reports, the catalogue guides foreign investment towards advanced manufacturing, modern services and the central, western and north-eastern regions and Hainan, fields that include green equipment and environmental services.
    据公开报道,该目录引导外资投向先进制造业、现代服务业以及中西部地区、东北地区和海南省,其中涵盖绿色装备与环境服务等领域。
  • For foreign investors, the practical read is that green-sector opportunities are framed by encouraged-catalogue entries and sector restrictions together, not by the energy clause alone.
    对外资而言,实务判断应同时看鼓励目录条目与分行业准入限制,而非仅凭能源条款。

Green and Low-Carbon Provisions in the Opinion on Developing New Quality Productive Forces | 《关于发展新质生产力的意见》绿色低碳条款解读

Overview

The Opinion on Developing New Quality Productive Forces, issued in October 2026, sets out a framework for China’s economic development. This article looks only at one dimension of it: the green and low-carbon provisions, and what they mean in practice for foreign companies active in green industries. It does not cover the Opinion’s wider structure or its provisions on foreign venture capital and data flows, which are addressed separately.

The relevant text sits in the third part of the Opinion, “focusing on innovating the development model”. It is short but specific, and it is best read alongside the existing investment framework rather than in isolation.

What the green and low-carbon clauses say

The third part opens by setting a direction: “focusing on innovating the development model; build a green, low-carbon and circular economic system, improve the policy toolbox for green development, and actively advance the energy revolution.”

The energy paragraph then elaborates. Focused on the carbon-peaking and carbon-neutrality goals, the text calls for:

  • the orderly development of advanced nuclear fission energy;
  • building a power system with a high proportion of renewable energy;
  • improving policies for the consumption and regulation of new energy;
  • organising demonstration and roll-out of major application scenarios, and accelerating the greening of energy use across production and daily life;
  • advancing the revolution in energy consumption, supply, technology and systems, and strengthening international co-operation in all respects.

Two features stand out. First, the clause pairs generation-side language — renewable power and nuclear fission — with consumption-side language — new-energy consumption and regulation. Second, it closes with “all-round international co-operation”, which places the energy transition within a cross-border frame rather than a purely domestic one. That closing phrase is the main hook for foreign participation, and it is a statement of direction rather than a list of specific openings.

Sector boundaries: nuclear power and the negative list

The phrase “orderly development of advanced nuclear fission energy” should be read carefully. It appears in a paragraph about the energy mix, and it signals that advanced nuclear fission is part of the long-term energy picture. It does not, by itself, change the rules on who may invest in nuclear power.

Nuclear power remains a sector governed by the Catalogue of Industries for Foreign Investment and the Negative List for Foreign Investment Access. Foreign investment in nuclear power is restricted, and specific access is subject to the current negative list. A reader should therefore treat the energy paragraph as a technology-and-supply statement, not as a statement that nuclear operations are open to foreign investment. Where a project touches nuclear, the applicable rule is the negative list as it stands, not the energy clause.

The same discipline applies to the renewable-energy language. The Opinion states a direction — a power system with a high proportion of renewables, and improved consumption and regulation policies. It does not, in this text, set out capacity targets or consumption ratios. Investors should rely on the specific implementing documents that follow, not on inferred numbers.

The encouraged-investment catalogue as the practical frame

For a foreign company in green industries, the operative document is the Catalogue of Industries for Encouraging Foreign Investment. According to public reports, the 2025 edition contains 1,679 entries in total, a net increase of 205 over the 2022 edition, with 303 entries revised. Of these, the national catalogue has 619 entries (100 added, 131 revised) and the catalogue for central and western regions and other areas has 1,060 entries (105 added, 172 revised). The catalogue guides foreign investment towards advanced manufacturing, modern services and the central, western and north-eastern regions and Hainan. It takes effect on 1 February 2026, when the 2022 edition is repealed.

These figures are reported by the media and should be treated as publicly reported information rather than as text of the Opinion. Their significance for green industries is that encouraged-catalogue entries are the main mechanism through which green manufacturing, new-energy equipment and environmental services are signalled as welcome areas. A company should check whether its activity appears in the catalogue, and should read that against the sector restrictions in the negative list.

Practical implications for foreign green-industry investors

The following are practical observations, not official commitments:

  • Read the two lists together. The encouraged catalogue and the negative list work as a pair. An activity can be encouraged in general and still restricted in a specific sub-sector; the negative list governs the restriction.
  • Match the technology to the direction. The Opinion’s language points to renewable generation, new-energy consumption and regulation, and demonstration scenarios. A company whose technology fits one of these directions has a clearer policy reference point.
  • Treat nuclear separately. Given that nuclear power is governed by the negative list, a nuclear-related project should be assessed under that regime rather than under the energy paragraph.
  • Watch for implementing documents. The Opinion sets direction. Capacity targets, consumption rules and incentive details will come through separate implementing documents; those, not the Opinion alone, will carry the operational detail.
  • Use the regional dimension. The encouraged catalogue’s regional sections indicate that investment in the central, western and north-eastern regions and Hainan is a specific focus, which may be relevant to siting decisions.

Related considerations

The Opinion also frames the transition as one that runs across consumption, supply, technology and systems, and it links this to international co-operation. For a foreign investor, the practical consequence is that green-industry opportunities in China are defined by the interaction of a policy direction, the encouraged-investment catalogue and the sector restrictions in the negative list. None of these alone is decisive. The Opinion provides the direction; the lists provide the operational boundaries; and the implementing documents that follow will provide the specifics.

Sources

  • 中国政府网:《关于发展新质生产力的意见》全文:https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网:新华社受权发布《关于发展新质生产力的意见》(含能源革命条款):https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml
  • 央视网:关于《关于发展新质生产力的意见》的报道:https://big5.cctv.com/gate/big5/news.cctv.cn/2026/10/09/ARTID24yrFP8npsds5YwTvhn261009.shtml

《关于发展新质生产力的意见》绿色低碳条款解读

概述

2026 年 10 月印发的《关于发展新质生产力的意见》,为中国的经济发展确立了框架。本文只聚焦其中一个维度:绿色低碳条款,以及它们对在华经营绿色产业的外资企业在实务上的含义。本文不涉及《意见》的整体结构,也不涉及其关于外资创业投资与数据流动的表述,这些内容另文处理。

相关条文位于《意见》第三方面”着力推进发展方式创新”。文字简短但指向明确,宜与现行投资制度框架对照阅读,而非孤立理解。

绿色低碳条款说了什么

第三方面开篇定下方向:”着力推进发展方式创新。构建绿色低碳循环发展经济体系,优化绿色发展政策工具箱,积极推进能源革命。”

能源段落随后展开。围绕碳达峰碳中和目标,文件提出:

  • 有序发展先进核裂变能;
  • 构建高比例可再生能源电力系统;
  • 完善新能源消纳和调控政策措施;
  • 组织重大应用场景示范和推广,加速全社会生产生活用能绿色化进程;
  • 推动能源消费、供给、技术、体制革命,全方位加强国际合作。

有两点较为突出。其一,该条将发电侧表述——可再生能源电力与核裂变能——与消费侧表述——新能源消纳与调控——并列。其二,它以”全方位加强国际合作”收尾,将能源转型置于跨境框架之内,而非纯粹的国内议题。这一收尾表述是外资参与的主要切入点,属于方向性表述,而非具体开放清单。

分行业边界:核电与负面清单

“有序发展先进核裂变能”一语需要审慎理解。它出现在关于能源结构的段落中,表明先进核裂变能属于长期能源图景的一部分。但它本身并不改变谁可以投资核电的规则。

核电仍属《外商投资准入负面清单》管理领域。外资进入核电受到限制,具体准入以现行负面清单为准。因此,读者应将能源段落视为技术与供给层面的表述,而非核电运营对外资开放的表述。凡涉及核电的项目,适用规则是现行负面清单,而非能源条款本身。

同样的纪律适用于可再生能源表述。《意见》表明的是方向——高比例可再生能源电力系统,以及完善的消纳与调控政策。就本文而言,它并未给出装机目标或消纳比例数字。投资者应依据后续具体实施文件,而非推断出的数字。

鼓励类目录作为实务框架

对绿色产业外资企业而言,起实际作用的是《鼓励外商投资产业目录》。据公开报道,2025 年版总条目 1679 条,比 2022 年版净增 205 条,修改 303 条。其中,全国目录 619 条(增加 100 条、修改 131 条),中西部等地区目录 1060 条(增加 105 条、修改 172 条)。该目录引导外资投向先进制造业、现代服务业以及中西部地区、东北地区和海南省,自 2026 年 2 月 1 日施行,2022 年版同时废止。

上述数据来自媒体报道,应视为公开报道信息,而非《意见》原文。其对绿色产业的意义在于:鼓励类目录条目,是绿色制造、新能源装备与环境服务被标示为欢迎领域的主要机制。企业应核查自身业务是否列入目录,并将其与负面清单中的分行业限制对照阅读。

外资绿色产业投资者的实务含义

以下为实务观察,不构成官方承诺:

  • 两份清单对照阅读。 鼓励类目录与负面清单是一组配套文件。某一业务可能总体受鼓励,却在具体子行业受限制;限制以负面清单为准。
  • 让技术与方向匹配。 《意见》的表述指向可再生能源发电、新能源消纳与调控,以及示范场景。技术与上述某一方向契合的企业,政策参照点更清晰。
  • 核电单独评估。 鉴于核电由负面清单管理,涉核项目应按该制度评估,而非按能源段落评估。
  • 关注实施文件。 《意见》确定方向。装机目标、消纳规则与激励细节将通过单独的实施文件落地;承载操作细节的是这些文件,而非《意见》本身。
  • 善用区域维度。 鼓励类目录的区域部分表明,投向中西部地区、东北地区和海南省是一项具体侧重,这可能与选址决策相关。

相关考虑

《意见》还将转型表述为贯穿消费、供给、技术与体制的过程,并将其与国际合作相联结。对境外投资者而言,实务上的结论是:中国的绿色产业机会,由政策方向、鼓励类目录与负面清单中的分行业限制三者互动界定。三者中的任何一项单独都不具决定性。《意见》提供方向,两份清单提供操作边界,后续实施文件将提供具体细节。

来源

  • 中国政府网:《关于发展新质生产力的意见》全文:https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网:新华社受权发布《关于发展新质生产力的意见》(含能源革命条款):https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml
  • 央视网:关于《关于发展新质生产力的意见》的报道:https://big5.cctv.com/gate/big5/news.cctv.cn/2026/10/09/ARTID24yrFP8npsds5YwTvhn261009.shtml

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors

  • Nine departments led by the Ministry of Industry and Information Technology have jointly issued the 15th Five-Year Plan for the Intelligent Connected New Energy Vehicle Industry; the co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.
    工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发《智能网联新能源汽车产业发展”十五五”规划》。
  • The 2030 targets are that China’s whole-industry-chain advantage in intelligent connected new energy vehicles is further consolidated and the country joins the ranks of the world’s automotive powers; new energy passenger vehicles are to reach 70% of new-vehicle sales in their respective segments and commercial vehicles 40%; and vehicles with autonomous-driving functions are to achieve large-scale application.
    到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列;国内新能源乘用车在各自领域新车总销量占比达 70%、商用车达 40%;具备自动驾驶功能的汽车实现规模应用。
  • The plan deploys five areas and 17 key tasks — raising technological innovation capability, upgrading the industrial system, promoting cross-sector integration, building a scientific and efficient industry-governance system, and opening a new chapter in global industrial cooperation — supported by four major projects and three priority actions.
    《规划》部署 5 方面 17 项重点任务:提高技术创新能力、推动产业体系优化升级、促进跨界融合发展、构建科学高效的行业治理体系、开创全球产业合作新局面;并配套 4 项重大工程与 3 项重点行动。
  • Capacity early-warning and control is written into an industry five-year plan for the first time: the plan tightens the conditions for establishing independent new energy vehicle makers, speeds up merger-and-reorganisation and the reform of grouped qualification management, and extends capacity control to power batteries by requiring stronger early-warning and control management of power-battery capacity.
    “产能预警调控”首次写入行业五年规划:严格新建独立新能源车企条件,兼并重组、资质集团化管理改革提速,并将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。
  • On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for comment 29 recommended national standard plan projects, including the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles; the comment period runs from 30 September to 29 October 2026.
    2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目,公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日。

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors | 中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

Overview

The Intelligent Connected New Energy Vehicle Industry “15th Five-Year Plan” was jointly issued by nine departments, led by the Ministry of Industry and Information Technology. The co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.

The plan sets the sector’s direction to 2030 across three layers: quantified market-share targets, an organising structure of tasks, projects and actions, and a governance layer that for the first time puts capacity early-warning and control into an industry five-year plan. Running alongside it is a standards programme, of which the most immediately relevant piece is a set of 29 recommended national standard plan projects opened for public comment in late September 2026.

The 2030 targets

By 2030, the plan aims for China’s whole-industry-chain advantage in intelligent connected new energy vehicles to be further consolidated, and for the country to join the ranks of the world’s automotive powers. Two quantified targets anchor the market dimension: new energy passenger vehicles are to account for 70% of new-vehicle sales in their respective segments, and commercial vehicles for 40%. On the technology dimension, the plan states that vehicles with autonomous-driving functions are to achieve large-scale application.

Five areas, 17 tasks, four projects, three actions

The plan deploys five areas and 17 key tasks: raising technological innovation capability; promoting the optimisation and upgrading of the industrial system; advancing cross-sector integrated development; building a scientific and efficient industry-governance system; and opening a new chapter in global industrial cooperation.

Four major projects support those tasks: the intelligent connected new energy vehicle key-technology breakthrough project; the standards and testing-evaluation capability improvement project; the intelligent connected new energy vehicle safety foundation project; and the internationalisation capability upgrade project.

Three priority actions translate the projects into workstreams: the “artificial intelligence plus automobile” development action; the key-component ecosystem development and leading-enterprise cultivation action; and the intelligent connected new energy vehicle application-promotion action.

Capacity early-warning and control enter a five-year plan

The governance layer is where the plan breaks new ground. Capacity early-warning and control is written into an industry five-year plan for the first time. In practice this shows up in three ways: the conditions for establishing independent new energy vehicle makers are tightened; merger and reorganisation and the reform of grouped qualification management are accelerated; and the reach of capacity control is extended to power batteries, with the plan calling for stronger early-warning and control management of power-battery capacity.

For a foreign investor weighing a new greenfield vehicle or battery plant, this is the provision that most directly changes the arithmetic: entry conditions, qualification structure and the capacity conversation are all being moved into a more managed framework.

The standards system: six specialised domains

The plan requires the continued development and improvement of specialised standards systems in six domains: automotive chips, automotive software, data governance and applications, automotive artificial intelligence, automotive solid-state batteries and low-carbon automotive development.

It also addresses market conduct: regulating the release of industry data and information and the payment of enterprise accounts; strengthening market-supervision enforcement; reinforcing anti-monopoly, anti-unfair-competition and price enforcement and justice; and intensifying quality supervision and inspection, defect investigation and product-consistency supervision and inspection.

The 29 draft national standards on supply-chain cybersecurity

On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for public comment 29 recommended national standard plan projects, among them the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles. The comment period runs from 30 September to 29 October 2026, and comments are submitted online through the “standards project initiation — project initiation publicity” section of the Ministry of Industry and Information Technology Standards Information Service Platform (https://std.miit.gov.cn).

The drafting of a supply-chain cybersecurity standard for intelligent connected vehicles sits directly under the plan’s automotive-software and automotive-artificial-intelligence standard domains. For suppliers, it is the earliest visible signal of the technical requirements that intelligent connected vehicle supply chains will be expected to meet.

Separately, the State Administration for Market Regulation (Standardization Administration of China) approved and released the national standard on automotive software quality and defect management around 14 September 2026, adding a quality-management counterpart to the technical standards workstream.

Global supply chain and foreign investment cooperation

The plan sets out to build a global industrial chain and supply chain, to improve overseas development service capability, and to support foreign-invested enterprises in investing and cooperating in China.

On 28 September 2026, at the press conference for the 2026 World Intelligent Connected Vehicle Conference, Hao Lishun, deputy director of the First Department of Equipment Industry of the Ministry of Industry and Information Technology, answered questions and set out three areas of work. First, making industrial chain and supply chain cooperation closer — including supporting foreign-invested enterprises in deepening their presence in the Chinese market. Second, deepening international coordination of standards and regulations — actively participating in international standards and regulations activities under mechanisms including the United Nations World Forum for Harmonization of Vehicle Regulations (WP.29), the International Organization for Standardization and the International Electrotechnical Commission, and promoting coordination in the development of standards and regulations for autonomous driving and electric vehicles. Third, making enterprises’ international development more stable — improving supporting arrangements such as cross-border logistics and investment and financing, strengthening overseas risk prevention and corporate compliance, and guiding enterprises to carry out overseas deployment in a prudent and orderly manner.

Judicial rules on AI-related disputes

On 7 September 2026 the Supreme People’s Court of China issued its Opinions on Trying Cases Involving Artificial-Intelligence-Related Disputes, which address liability where a vehicle defect and driver fault cause the same damage, and liability for misleading promotion of a vehicle’s automation level, intelligence, performance or use.

Practical notes for foreign investors

  • Read the capacity layer first. The tightening of conditions for new independent NEV makers and the extension of capacity control to batteries are the provisions that shape whether a new plant is approvable.
  • Track the six standard domains. Automotive chips, software, data governance, automotive AI, solid-state batteries and low-carbon development are the areas where technical requirements will be formalised.
  • Follow the 29 draft standards. Supply-chain cybersecurity is the first of the batch to watch, with comments open until 29 October 2026.
  • Use the cooperation channels. The plan and the 28 September briefing both explicitly support foreign-invested enterprises deepening their China presence and participating in international standards work under WP.29, ISO and IEC.

Sources

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

Related reading

  • see also: 智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • see also: 机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

概述

《智能网联新能源汽车产业发展”十五五”规划》由工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发。

规划以三个层次界定 2030 年前的方向:量化的市场份额目标;由重点任务、重大工程、重点行动构成的推进结构;以及首次把产能预警调控写入行业五年规划的治理层。与之并行的是标准工作,其中与产业主体最直接相关的一项,是 2026 年 9 月下旬公开征求意见的 29 项推荐性国家标准计划项目。

2030 年目标

规划提出,到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列。市场维度有两个量化目标锚定:国内新能源乘用车在各自领域新车总销量占比达 70%,商用车达 40%。技术维度上,规划提出具备自动驾驶功能的汽车实现规模应用。

5 方面 17 项任务、4 项工程、3 项行动

规划部署 5 方面 17 项重点任务:提高技术创新能力;推动产业体系优化升级;促进跨界融合发展;构建科学高效的行业治理体系;开创全球产业合作新局面。

4 项重大工程为上述任务提供支撑:智能网联新能源汽车关键技术攻关工程;标准及测试评价能力提升工程;智能网联新能源汽车安全筑基工程;国际化能力跃升工程。

3 项重点行动把工程转化为具体工作流:”人工智能+汽车”发展行动;关键零部件生态建设和领军企业培育行动;智能网联新能源汽车应用推广行动。

产能预警调控首次写入五年规划

治理层是规划的突破之处。”产能预警调控”首次写入行业五年规划。具体体现为三条:严格新建独立新能源车企条件;兼并重组、资质集团化管理改革提速;将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。

对正在评估新建整车或电池工厂的外国投资者而言,这一条最直接地改变测算:准入条件、资质结构与产能议题,都被移入一个更强调管理的框架之中。

标准体系:六个专项领域

规划要求持续建立完善六个专项标准体系:汽车芯片、汽车软件、数据治理及应用、汽车人工智能、车用固态电池、汽车低碳发展。

规划同时规范市场行为:规范行业数据信息发布和企业账款支付;加强市场监管执法;强化反垄断、反不正当竞争和价格执法司法;加强质量监督检查、缺陷调查和产品一致性监督检查力度。

供应链网络安全:29 项国家标准立项公示

2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目。公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日,意见通过”工业和信息化标准信息服务平台”(https://std.miit.gov.cn)”标准立项—立项公示”栏目在线反馈。

智能网联汽车供应链网络安全标准的立项,正落在规划的汽车软件与汽车人工智能两个标准领域之下。对供应商而言,这是智能网联汽车供应链将要满足的技术要求最早可见的信号。

此外,市场监管总局(国家标准委)于 2026 年 9 月 14 日前后批准发布《汽车软件质量与缺陷管理规范》国家标准,为技术标准工作补充了质量管理维度的对应文件。

全球产业链供应链与外资合作

规划提出构建全球产业链供应链、提升海外发展服务能力、支持外资企业在华投资合作等目标任务。

2026 年 9 月 28 日,在 2026 世界智能网联汽车大会新闻发布会上,工业和信息化部装备工业一司副司长郝立顺答记者问,明确工信部将重点做好三方面工作。其一,推动产业链供应链合作更加紧密,包括支持外资企业深耕中国市场。其二,推动标准法规国际协同更加深入,积极参与联合国世界车辆法规协调组织(WP.29)、国际标准化组织、国际电工委员会等机制下的国际标准法规活动,推动自动驾驶、电动汽车等标准法规制定协调。其三,推动企业国际化发展更加稳健,完善跨境物流、投融资等配套支撑,加强海外风险防范和企业合规建设,引导企业稳妥有序开展海外布局。

涉人工智能纠纷案件的司法规则

2026 年 9 月 7 日,中国最高人民法院发布《关于依法审理涉人工智能纠纷案件的意见》,对车辆缺陷与驾驶人过错行为结合致损的责任,以及对车辆自动化等级、智能程度、性能、用途等作虚假或者引人误解宣传的责任作出规定。

外资企业实务提示

  • 先读产能层。 严格新建独立新能源车企条件,以及产能调控向电池环节延伸,是决定新建工厂能否获批的条款。
  • 跟踪六个标准领域。 汽车芯片、汽车软件、数据治理、汽车人工智能、车用固态电池与汽车低碳发展,是技术要求将被正式化的方向。
  • 关注 29 项立项公示。 供应链网络安全是本批中最值得跟踪的一项,意见反馈开放至 2026 年 10 月 29 日。
  • 用好合作通道。 规划与 9 月 28 日发布会均明确支持外资企业深耕中国市场,并参与 WP.29、ISO、IEC 机制下的国际标准工作。

来源

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

相关阅读

  • 见:智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • 见:机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain

  • The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (商资发〔2026〕97号, issued 16 June 2026 by MOFCOM, NDRC and MOF) commits the government to “expedite the study and issuance of implementation rules for segmented pharmaceutical production”, easing cross-border segmented manufacturing of biologics and chemical drugs by foreign marketing-authorisation holders.
    商务部、国家发展改革委、财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号,2026年6月16日印发)明确”抓紧研究出台药品分段生产实施细则”,便利境外药品上市许可持有人开展生物制品、化学药品跨境分段生产。
  • The same plan moves to widen pilot geography: authorities will “expedite research and approval to further expand the pilot regions for biotechnology and wholly foreign-owned hospitals” — the two most-watched restricted-service openings of the current cycle.
    同一方案还推动试点扩围:”抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围”——这是本轮最受关注的两项限制性服务业开放。
  • The statutory base is already in place: the revised Drug Administration Law Implementation Regulations (published January 2026) turned segmented production from pilot into institution, letting marketing-authorisation holders commission qualified producers to segment-manufacture innovative drugs and clinically urgent drugs when genuinely needed, under a unified quality-assurance system covering all sites.
    法定底座已经就位:修订后的《药品管理法实施条例》(2026年1月公布)把分段生产从试点推向制度——药品上市许可持有人确有需要的,可委托符合条件的企业分段生产创新药、临床急需药品等,并建立覆盖全部生产场地的统一质量保证体系。
  • Commercial proof-of-concept has landed: in May 2026 Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance in China, with the substance made by WuXi Bio in Wuxi and fill-finish completed in Germany.
    商业验证已经落地:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂在德国完成。
  • Biotech opening pilots are producing registrable outcomes: under the 2024 pilot allowing FIEs to develop and apply human stem-cell and gene diagnosis and therapy technologies in designated free trade zones, at least six foreign companies — including Merck, JW Therapeutics-related entities, Frontera Therapeutics and StarCellBio — have completed registration changes or new filings.
    生物技术开放试点已产出可登记成果:在2024年允许外商投资企业于指定自贸区开展人体干细胞、基因诊断与治疗技术开发应用的试点下,至少6家外资企业(含默克、药明巨诺相关主体、芳拓生物、星奕昂等)已完成经营范围变更或新设登记。
  • Payment and channel measures complete the chain: the plan supports insurers in covering more innovative drugs and devices under commercial health insurance, and calls for an industry collaboration platform to smooth foreign-made pharmaceuticals into retail channels — the “last mile” that has capped foreign pharma revenue in China.
    支付与渠道措施补齐链条:方案支持保险公司将更多创新药械纳入商业保险保障范围,并搭建行业协作平台便利外资企业生产的药品进入零售渠道——这正是此前封顶外资药企中国收入的”最后一公里”。

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain | 外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

Overview

The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (《利用外资固稳促优行动方案》, 商资发〔2026〕97号), issued on 16 June 2026 by the Ministry of Commerce, the National Development and Reform Commission and the Ministry of Finance with State Council consent, devotes one of its fifteen measures to pharmaceuticals. The measure assembles a “production — marketing-authorisation — payment — channel” package for foreign pharmaceutical and biotech companies: segmented production implementation rules, expanded pilot geography for biotechnology and wholly foreign-owned hospitals, commercial-insurance payment support, and retail-channel facilitation.

With September 2026 commentary from the Shanghai government’s weekly foreign-invested information service now tracking the package in detail, the measures are the clearest single statement of where foreign pharma market access in China is heading this cycle.

Segmented production: from pilot to statute to rules

Segmented production (分段生产) distributes a drug’s manufacturing process across sites or companies — globally common, but long restricted in China. The progression:

  • October 2024: the National Medical Products Administration issued the pilot work plan for segmented production of biologics, allowing certain innovative and clinically urgent biologics to run segmented production at the pilot stage.
  • January 2026: the State Council published the revised Drug Administration Law Implementation Regulations, moving segmented production into institution. Article 31 provides that where a marketing-authorisation holder genuinely needs it, the holder may commission qualified manufacturers to segment-manufacture (i) innovative drugs with special process, facility or equipment requirements, (ii) clinically urgent drugs and drugs needed for public-health response or reserves identified by the State Council departments, and (iii) other drugs specified by the drug regulator. The holder must build a unified quality-assurance system covering the whole production process and all sites; vaccines and blood products carry their own commissioning rules.
  • Next step: the action plan’s commitment to issue implementation rules for segmented pharmaceutical production — the operational layer for application conditions, quality-responsibility allocation and regulatory coordination.

The commercial template already exists: in May 2026, Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance — substance produced by WuXi Biologics in Wuxi, fill-finish completed by Vetter Pharma in Germany. For multinationals, the case demonstrates the operating model the rules will generalise: foreign marketing-authorisation holders placing upstream segments with qualified Chinese CDMOs while keeping downstream finishing abroad, or the reverse.

Biotechnology and wholly foreign-owned hospitals: pilot expansion pending approval

Biotechnology (human stem cells, gene diagnosis and therapy) has been open to FIEs only inside designated pilot areas since September 2024, when Beijing, Shanghai and Guangdong free trade zones and Hainan were authorised. The registry shows results: at least six foreign companies — including Merck, entities associated with JW Therapeutics (药明巨诺), Frontera Therapeutics (芳拓生物) and StarCellBio (星奕昂) — have completed business-scope changes or new registrations inside the pilot areas.

The action plan instructs authorities to expedite research and approval for expanding the pilot regions for both biotechnology and wholly foreign-owned hospitals — the same two openings that Shanghai’s 15th Five-Year plan and other provincial documents name as landing priorities. Neither expansion has been formally approved yet; the plan converts the expansion from discussion item into an official workstream with a deadline pressure attached.

Payment and channels: the last-mile package

Two measures address the revenue side that has historically capped foreign pharma’s China performance:

  • Commercial insurance. The plan supports insurers in bringing more innovative drugs and devices into commercial health-insurance coverage — the payer channel that has grown fastest as national reimbursement negotiations compress prices.
  • Retail channels. An industry collaboration platform will be built to facilitate foreign-produced pharmaceuticals entering drug retail channels — addressing the distribution friction that has kept foreign-manufactured drugs out of pharmacy chains even after approval.

What this means for foreign pharma and healthcare groups

  • Map your product portfolio against segmented-production eligibility. The statutory categories are innovative drugs with special process/equipment requirements and clinically urgent or reserve drugs; groups with biologics or special-technology chemicals should identify candidates and pre-qualify Chinese CDMO partners under a unified quality system.
  • Watch the implementation rules, not just the plan. Application conditions, quality-responsibility division and regulatory coordination sit in the forthcoming rules; the drafting is the moment to submit practical comments.
  • Treat pilot expansion as a siting decision. If the biotech and wholly-owned-hospital pilots extend to new provinces, entity location inside a pilot area becomes a structuring variable; hold new China healthcare investments until the expanded map is published.
  • Build the commercial-insurance and retail strategy now. Payment support and retail-channel facilitation are revenue-side measures; groups that prepare health-insurance dossiers and pharmacy distribution agreements can move when the platforms land.
  • Benchmark against the niccalimab case. The first segmented-production precedent defines the documentation and quality-system expectations regulators will apply to the next applications.

Sources

  • 济源产城融合示范区管理委员会(转载)— 商务部 国家发展改革委 财政部关于印发《利用外资固稳促优行动方案》的通知(商资发〔2026〕97号,2026年6月16日,政府官网全文): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期,总第157期,2026年9月2日,医药开放组合与分段生产制度演进综述): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(2026年修订版分段生产条款第31—33条全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

Related reading

  • see also: segmented pharma production pilot mechanics (segmented-pharma-production)
  • see also: wholly foreign-owned hospital pilot requirements (foreign-owned-hospital-pilot)

外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

概述

《利用外资固稳促优行动方案》(商资发〔2026〕97号)由商务部、国家发展改革委、财政部经国务院同意于2026年6月16日印发,其十五条举措中专设一条指向医药。该条为外资医药与生物技术企业组装了一套”生产—上市许可—支付—渠道”组合:分段生产实施细则、生物技术与外商独资医院试点扩围、商业保险支付支持与零售渠道便利。

随着2026年9月上海市政府涉外资讯周报对该政策包作出详细追踪解读,这是本周期内中国外资药品准入走向最清晰的一份单项表述。

分段生产:从试点到法定再到细则

分段生产(分段生产)把药品生产过程分布在不同场地或企业之间——全球通行,但在中国长期受限。演进脉络:

  • 2024年10月: 国家药监局印发生物制品分段生产试点工作方案,允许部分创新生物制品和临床急需生物制品在试点阶段开展分段生产。
  • 2026年1月: 国务院公布修订后的《药品管理法实施条例》,把分段生产推向制度。第三十一条规定,药品上市许可持有人确有需要的,可以委托符合条件的药品生产企业分段生产:(一)生产工艺、设施设备有特殊要求的创新药;(二)临床急需药品、应对突发公共卫生事件急需或储备需要的药品;(三)国务院药品监督管理部门规定的其他药品。持有人须建立覆盖药品生产全过程和全部生产场地的统一质量保证体系;疫苗、血液制品另有委托生产规则。
  • 下一步: 行动方案承诺出台药品分段生产实施细则——即申请条件、质量责任划分与监管协调的操作层。

商业模板已经出现:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂由德国Vetter Pharma完成。对跨国药企而言,该案例演示了细则将要推广的运营模式:境外持有人把上游环节放在中国合格CDMO、下游制剂留在境外,或反向操作。

生物技术与外商独资医院:扩围报批中

自2024年9月北京、上海、广东自贸区和海南获准试点以来,生物技术(人体干细胞、基因诊断与治疗)仅对试点区域内FIE开放。登记情况已有产出:至少6家外资企业——包括默克、药明巨诺相关主体、芳拓生物(Frontera Therapeutics)、星奕昂等——已在试点区域内完成经营范围变更或新设登记。

行动方案要求抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围——上海”十五五”规划等省级文件点名的同样是这两项开放。扩围尚未正式获批;方案把扩围从讨论事项转为带时限压力的正式工作流程。

支付与渠道:最后一公里

两项措施指向历史上封顶外资药企中国收入的收入端:

  • 商业保险。 方案支持保险公司将更多创新药械纳入商业健康保险保障范围——在国家谈判压缩价格背景下增长最快的支付通道。
  • 零售渠道。 将搭建行业协作平台,便利外资企业生产的药品进入药品零售渠道——解决获批外资药品难以进入连锁药店的流通摩擦。

对外资医药与医疗集团的启示

  • 对照分段生产法定情形梳理产品组合。 法定类别是工艺设施有特殊要求的创新药与临床急需、储备药品;拥有生物制品或特殊工艺化学药的企业应识别候选产品,并按统一质量体系预审中国CDMO伙伴。
  • 盯细则而不止于方案。 申请条件、质量责任划分与监管协调都在即将出台的实施细则中;起草阶段是提交实务意见的窗口。
  • 把试点扩围当作选址变量。 若生物技术与独资医院试点扩展至新省份,主体落位在试点区域内就成为架构变量;新医疗投资可等扩围地图公布后再定。
  • 现在就建商保与零售策略。 支付支持与渠道便利是收入端措施;提前准备健康险材料与药店分销协议的集团,可在平台落地时立即行动。
  • 对标尼卡利单抗案例。 首个分段生产先例界定了监管对后续申请的单证与质量体系预期。

来源

  • 济源产城融合示范区管理委员会(转载)— 《利用外资固稳促优行动方案》通知全文(商资发〔2026〕97号): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(分段生产条款全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

相关阅读

  • 见:药品分段生产试点机制要点(segmented-pharma-production)
  • 见:外商独资医院试点要求(foreign-owned-hospital-pilot)

Dalian’s Services-Opening Pilot Goes Operational: Medical Access Guides and the Implementation Plan

  • In August 2026 Dalian stepped up its services-opening pilot: the municipal commerce bureau opened a 7-day public comment on the Dalian Implementation Plan for the Services Industry Expansion and Opening Comprehensive Pilot (draft), while the municipal health commission issued three compliance guides for foreign doctors opening clinics, foreign-invested non-profit medical institutions and short-term practice by overseas physicians.
    2026 年 8 月,大连加码服务业扩大开放试点:市商务局对《大连市服务业扩大开放综合试点实施方案(草案)》公开征求意见(7 天);市卫生健康委发布三项合规办事指引,覆盖外籍及港澳台医生开设诊所、中外合资合作非营利性医疗机构、境外医师短期执业。
  • Dalian is one of nine cities — together with Ningbo, Xiamen, Qingdao, Shenzhen, Hefei, Fuzhou, Xi’an and Suzhou — added to the national services-opening pilot in 2025, carrying 159 pilot tasks assigned by the Ministry of Commerce in January 2026.
    大连是 2025 年新增的 9 个服务业扩大开放综合试点城市之一(另有宁波、厦门、青岛、深圳、合肥、福州、西安、苏州),承接商务部 2026 年 1 月赋予的 159 项试点任务。
  • The medical guides convert national pilot tasks into standardised filing procedures: clear legal bases, applicant conditions, document checklists and process steps for overseas medical professionals and institutions to practise or establish entities in Dalian.
    医疗三项指引把国家试点任务转化为标准化审批办事规范:明确境外医疗人才、机构来连执业办医的办理依据、申请条件、申报材料与办理流程。
  • The pilot tasks cover telecom services, healthcare, business, culture and tourism and finance, with each city encouraged to design distinctive tasks based on local strengths — Dalian’s health-sector focus reflects its industrial base.
    试点任务覆盖电信服务、医疗康养、商贸文旅、金融等重点领域,鼓励各城市结合自身优势设计个性化任务——大连聚焦医疗审批改革与其产业基础契合。
  • For foreign healthcare providers, the practical entry point is clear: use the three Dalian guides to prepare clinic-licensing or short-term-practice filings, and watch the city’s implementation plan for wider services-opening commitments.
    对外资医疗机构与境外医师,实操入口明确:按大连三项指引准备诊所设置或短期执业申报,并关注该市实施方案中的更广开放承诺。

Dalian’s Services-Opening Pilot Goes Operational: Medical Access Guides and the Implementation Plan | 大连服务业扩大开放试点落地:医疗开放指引与实施方案

From national pilot to city-level rules

Dalian was one of nine cities added to the national services industry expansion and opening comprehensive pilot in 2025 — together with Ningbo, Xiamen, Qingdao, Shenzhen, Hefei, Fuzhou, Xi’an and Suzhou — bringing the pilot network to 20 cities. In January 2026 the Ministry of Commerce issued the pilot tasks for these nine cities: 159 tasks spanning telecom services, medical and healthcare, business, culture and tourism, and finance, with a “common plus distinctive” structure that lets each city combine national commitments with locally tailored measures. In August 2026 Dalian translated this national framework into local, operational rules. On 20 August the municipal commerce bureau published the Dalian Implementation Plan for the Services Industry Expansion and Opening Comprehensive Pilot (draft) for a seven-day public comment period. Days earlier, the municipal health commission released three compliance guides covering the healthcare tasks.

The three medical compliance guides

The three guides issued by the Dalian health commission are: (1) the Compliance Guide for Foreign and Hong Kong, Macao and Taiwan Doctors Opening Clinics in Dalian; (2) the Compliance Guide for Applying to Establish Sino-foreign Jointly Invested or Co-operated Non-Profit Medical Institutions in Dalian; and (3) the Compliance Guide for Overseas Physicians Conducting Short-Term Practice in Accordance with Regulations in Dalian. Each guide standardises the approval chain end to end: the legal basis, applicant conditions, required documents and the filing process, converting national pilot tasks into the day-to-day norms that local regulators will apply. The three areas covered — foreign doctors’ clinics, short-term practice by overseas physicians and non-profit joint medical institutions — correspond exactly to the tasks the national pilot assigns to the healthcare sector.

What the draft implementation plan signals

The draft implementation plan, open for comment until 26 August, sets out how Dalian will implement the 159 tasks more broadly. It is grounded in the MOFCOM notice on the nine-city pilot tasks (Shang Zi Han [2026] No. 5) and, once finalised, will be the reference document for foreign investors assessing Dalian’s services sector. Combined with the medical guides, it signals that Dalian intends to be a practical testbed: national policy is being converted into city-level processes that businesses can follow, rather than left as abstract commitments.

Why it matters for foreign healthcare and services investors

For foreign healthcare providers, the package matters for three reasons. First, entry clarity: the three guides specify exactly what an overseas physician needs to open a clinic or practise short-term in Dalian — reducing the uncertainty that historically surrounded medical licensing for foreign professionals. Second, breadth: the implementation plan, once final, will clarify Dalian’s approach to telecom, business, culture and tourism and finance tasks, helping investors see the full opening landscape rather than a single sector. Third, precedent value: Dalian is among the first of the nine 2025-vintage pilot cities to convert its tasks into published compliance guides, so the format is likely to be imitated by other cities — making the Dalian documents useful templates for understanding how services opening is being operationalised across China.

Practical steps

Foreign investors and medical professionals should: (1) review the three health-commission guides against their specific plans — clinic establishment, short-term practice or a non-profit joint institution — and assemble the document package each guide lists; (2) engage the Dalian health commission early on applicant qualifications, since foreign-doctor clinic rules require careful checking of professional credentials and prior practice records; (3) track the finalised version of the implementation plan through the Dalian commerce bureau for wider services commitments; and (4) for investors comparing Chinese cities, treat Dalian’s published guides as one example of how the nine-city pilot tasks are being implemented, and benchmark against the progress of peer cities such as Fuzhou, Shenzhen and Xi’an.

The wider context: services opening as a national agenda

Dalian’s package sits inside a broader national push that foreign investors should read as a trend, not a one-off. The “15th Five-Year Plan” outline treats services as the main front of opening: expanding market access in telecom, internet, education, culture and healthcare, and steadily running the value-added telecom, biotech and wholly foreign-owned hospital pilots. Two negative lists are the operational instruments — the foreign-investment negative list and the cross-border services trade negative list — and pilot FTZs and services-opening pilot cities are the testbeds. For a foreign services provider, the practical implication is that city-level documents like Dalian’s implementation plan and compliance guides are where national commitments become enforceable processes; monitoring them is the difference between reading about opening and actually entering a market. The same mechanics — a national task, a local implementation plan, sector-specific compliance guides — are being replicated across the nine new pilot cities, so a company that understands Dalian’s format can apply the same analytical lens to Fuzhou, Shenzhen, Qingdao and the rest.

Sources


大连服务业扩大开放试点落地:医疗开放指引与实施方案

从国家试点到市级规则

大连是 2025 年新增的 9 个服务业扩大开放综合试点城市之一(另有宁波、厦门、青岛、深圳、合肥、福州、西安、苏州),试点网络由此扩围至 20 城。2026 年 1 月,商务部印发 9 城市服务业扩大开放综合试点任务:159 项任务覆盖电信服务、医疗康养、商贸文旅、金融等领域,采用”共性+个性”结构,鼓励各城市把国家承诺与本地特色结合。2026 年 8 月,大连将国家框架转化为本地操作性规则。8 月 20 日,市商务局发布《大连市服务业扩大开放综合试点实施方案(草案)》并公开征求意见(7 天);此前数日,市卫生健康委发布覆盖医疗领域试点任务的三项合规办事指引。

三项医疗合规指引

大连市卫健委发布的三项指引为:(1)《大连市外籍及港澳台医生开设诊所合规办事指引》;(2)《大连市申办中外合资、合作非营利性医疗机构合规办事指引》;(3)《大连市境外医师按规定从事短期执业活动合规办事指引》。每项指引对审批链条做全流程标准化:办理依据、申请条件、申报材料、办理流程,把国家试点任务转化为地方监管日常适用的规范。三个覆盖领域——外籍医生诊所、境外医师短期执业、中外合资非营利性医疗机构——与全国试点赋予医疗行业的任务一一对应。

实施方案草案的信号

实施方案草案(征求意见截止 8 月 26 日)明确大连将如何更广地落实 159 项任务。文件依据商务部 9 城市试点任务通知(商资函〔2026〕5 号)制定,定稿后将成为外资投资者评估大连服务业的参考文件。与医疗指引结合,方案传递的信号是:大连要做实操试验田——国家政策被转化为企业可遵循的城市级流程,而非停留在抽象承诺。

对外资医疗与服务投资者的意义

对外资医疗机构,这一揽子安排有三重意义。第一,准入清晰:三项指引精确说明境外医师在大连开设诊所或短期执业需要什么,降低了外籍医疗执业许可长期以来的不确定性。第二,广度:实施方案定稿后将明确大连对电信、商贸、文旅、金融任务的态度,投资者可见全貌而非单一行业。第三,先例价值:大连是 2025 年批次 9 城市中率先把试点任务转化为公开合规指引的城市之一,格式很可能被其他城市效仿——大连文件因此成为理解全国服务业开放如何落地化的有用模板。

操作建议

外资投资者与境外医疗专业人士应:(1)对照三项指引核对自己的具体计划——开设诊所、短期执业或非营利性合资机构——并按指引清单准备材料包;(2)尽早与大连市卫健委沟通申请人资质,外籍医生诊所规则对执业资格与既往执业记录核对要求细致;(3)通过市商务局跟踪实施方案定稿版,获取更广服务承诺;(4)比较不同中国城市时,把大连的公开指引视为 9 城市试点任务落地的一个样本,并与福州、深圳、西安等同批城市进展对标。

更大背景:服务业开放作为国家议程

大连的一揽子安排处在一个更广的国家推进之中,外国投资者应视之为趋势而非一次性事件。”十五五”规划纲要视服务业为开放主战场:推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点。两张负面清单是操作工具——外商投资准入负面清单与跨境服务贸易负面清单——自贸试验区与服务业扩大开放试点城市是试验田。对外资服务商,实际含义是:像大连实施方案与合规指引这样的城市级文件,正是国家承诺转化为可执行流程之处;跟踪它们是”读到开放”与”真正进入市场”的区别。同一机制——国家任务、地方实施方案、分行业合规指引——正在 9 个新增试点城市复制,理解了大连格式的企业可以把同样的分析框架套用于福州、深圳、青岛等城市。

Sources

Sector-by-Sector Opening in 2026: Hospitals, Telecoms and Services Pilots

  • The State Council’s National Health 15th Five-Year Plan (Guo Fa [2026] No. 23) explicitly calls for expanding the wholly foreign-owned hospital pilot and steadily advancing international medical services pilots.
    国务院《国民健康”十五五”规划》(国发〔2026〕23 号)明确提出”推动医疗领域有序扩大开放,进一步扩大外商独资医院开放试点,稳妥推进国际医疗服务试点”。
  • Wholly foreign-owned hospital pilots now cover nine locations — Beijing, Shanghai, Tianjin, Nanjing, Suzhou, Fuzhou, Guangdong, Shenzhen and all of Hainan — with foreign hospitals landing in 2026 (e.g. Pengruili International Hospital, Fuzhou Xingyao Eye Hospital).
    外商独资医院试点已覆盖北京、上海、天津、南京、苏州、福州、广东、深圳及海南全岛 9 个地方,2026 年外资医院加速落地(如鹏瑞利国际医院、福州星耀眼科医院)。
  • Value-added telecoms opening continues at scale: 166 foreign enterprises have received pilot approvals since February 2025, covering all ten value-added telecom business categories, and foreign-invested telecom enterprises nationwide exceed 3,100.
    增值电信开放持续推进:2025 年 2 月以来已有 166 家外资企业获经营试点批复,覆盖全部 10 项增值电信业务;全国外商投资电信企业超 3100 家。
  • Education, finance and services opening are broadening in parallel: nine new services-opening comprehensive pilot cities since 2025, foreign vocational training pilots, and more foreign institutions using fund-investment and risk-management tools.
    教育、金融等服务业开放同步拓宽:2025 年以来服务业扩大开放综合试点新增 9 个城市,推进职业技能培训开放试点,支持外资机构运用基金投顾与风险管理工具。
  • The National Health Plan also advances innovation-drug and medical-device channels, commercial insurance coverage of innovative drugs, and AI-enabled pharma value chains — relevant to foreign pharma and device companies entering China.
    《国民健康”十五五”规划》还推进创新药械审评审批、商业保险覆盖创新药、人工智能赋能医药全产业链,对进入中国的外资药械企业直接相关。
  • For foreign investors, the practical takeaway is that sector restrictions are being dismantled industry by industry through pilots: confirm whether the target sector is in an expanded pilot, prepare the sectoral licence application early, and use the provincial commerce one-stop channels.
    对外国投资者,实操要点是分行业限制正通过试点逐行业拆除:确认目标行业是否在扩容试点内、尽早准备行业牌照申请、善用省级商务一站式通道。

Sector-by-Sector Opening in 2026: Hospitals, Telecoms and Services Pilots | 2026 年分行业开放:医院、电信与服务业试点

Why this matters now

China’s sector restrictions on foreign investment are being dismantled industry by industry through pilot programmes rather than through a single omnibus measure. Three tracks are moving in parallel in 2026. First, healthcare: the State Council’s National Health 15th Five-Year Plan (Guo Fa [2026] No. 23) explicitly supports expanding the wholly foreign-owned hospital pilot and advancing international medical services pilots, and wholly foreign-owned hospital pilots already cover nine locations. Second, telecoms: the value-added telecoms pilot has issued approvals to 166 foreign enterprises since February 2025, covering all ten value-added categories. Third, education and finance: the services-opening comprehensive pilots added nine new cities in 2025, and the utilisation of foreign capital action plan supports foreign vocational training institutions, fund-investment advisory and risk-management tools for foreign institutions. For foreign companies whose target sector still carries restrictions, the operative question is which pilot applies and how the licence process runs. This article maps the 2026 sector-opening landscape.

Healthcare: hospital and pharma channels

The National Health 15th Five-Year Plan, issued under Guo Fa [2026] No. 23, directs orderly expansion of medical-sector opening, further expansion of the wholly foreign-owned hospital pilot and steady advancement of international medical services pilots. The hospital pilot already covers Beijing, Shanghai, Tianjin, Nanjing, Suzhou, Fuzhou, Guangdong, Shenzhen and the whole of Hainan. Foreign hospital groups have been landing: Pengruili International Hospital, Fuzhou Xingyao Eye Hospital and Nanjing Hanmei Viti Cosmetic Hospital are cited as examples of foreign-invested hospitals entering the market. The plan also supports optimised review and approval for innovative and clinically urgent drugs, commercial insurance coverage of innovative drugs and medical devices, and AI-enabled pharma value chains. For foreign pharma and device companies, the plan signals sustained demand-side support for innovative products alongside the supply-side opening of hospital ownership.

Telecoms: the value-added pilot at scale

The value-added telecoms pilot, launched in October 2024 in Beijing (services opening-up comprehensive demonstration zone), the Shanghai FTZ Lin-gang New Area and Shanghai’s socialist modernisation leading zone, Hainan Free Trade Port and Shenzhen’s socialist demonstration zone, removed foreign shareholding caps on specified value-added services including internet data centres (IDC), content delivery networks (CDN), internet access services (ISP), online data processing and transaction processing, and information publication platform services. Since the first batch of approvals in February 2025, 166 foreign enterprises have received pilot approvals, and some wholly foreign-owned enterprises have obtained IDC qualifications — relevant for AI data-centre investment. Nationwide, foreign-invested telecom enterprises exceed 3,100, covering all ten value-added categories under the Telecommunications Business Classification Catalogue. The utilisation of foreign capital action plan supports continuing and expanding the pilot.

Education and finance

Education opening is advancing through the services-opening comprehensive pilots, which added nine new cities in 2025, and through the action plan’s commitment to steadily expand pilots for foreign vocational training institutions, vocational colleges and high-level science, engineering, agriculture and medicine universities. In finance, the action plan supports more foreign institutions using risk-management tools including government bond futures, foreign institutions carrying out fund-investment advisory business, and facilitation of cross-border business for key foreign-invested enterprises. These items matter for foreign financial institutions and education groups assessing entry.

How sector pilots actually run

Each pilot follows the same shape: a national policy statement names the sector and the pilot regions; the competent ministry (NHSA/MOFCOM for hospitals, MIIT for telecoms, MOE for education) issues implementation rules; provincial authorities process applications; and foreign enterprises apply for the sectoral licence or approval. For hospitals, the provincial health commission and commerce department jointly review the establishment; for value-added telecoms, MIIT issues the pilot approval and the enterprise obtains the value-added telecom business licence (ICP/EDI) locally; for education, the MOE approves cooperative or independent institutions. Timing differs: hospital establishment can take months of review; telecoms approvals have been issued in batches; education approvals follow the MOE’s periodic batches.

Practical steps

First, verify the target sector’s current restriction level: full opening, pilot opening, conditional or prohibited. Second, where a pilot applies, confirm the pilot region covers the planned location and that the business line is within the pilot’s service scope. Third, prepare the sectoral application package: for hospitals, the feasibility study, qualifications of the foreign hospital group, and the cooperation or independent-establishment plan; for telecoms, the corporate structure demonstrating shareholding compliance and the security assessment materials; for education, the partner credentials and curriculum plan. Fourth, engage the provincial commerce department’s one-stop window and the competent ministry’s pre-communication channel early. Fifth, monitor pilot expansion announcements — hospital, biotech and telecom expansions are explicitly in the pipeline.

Compliance notes

Sector pilots do not remove all restrictions: negative-list limits still apply to fields outside the pilots, and each licence carries conditions (e.g. service scope, foreign shareholding, security review for telecoms). The National Health Plan is a planning document; implementing rules for hospital and international medical pilots will follow from the competent authorities. Foreign investors should not assume that a pilot in one region extends to others, and should confirm current regional scope before committing.


2026 年分行业开放:医院、电信与服务业试点

为什么当下重要

中国对外资的分行业限制正通过试点逐行业拆除,而非依赖一部一揽子法规。2026 年有三条线并行推进。其一,医疗:国务院《国民健康”十五五”规划》(国发〔2026〕23 号)明确提出扩大外商独资医院开放试点、稳妥推进国际医疗服务试点,外商独资医院试点已覆盖 9 个地方。其二,电信:增值电信开放试点自 2025 年 2 月以来已向 166 家外资企业发放经营批复,覆盖全部 10 项增值电信业务。其三,教育与金融:服务业扩大开放综合试点 2025 年新增 9 个城市,稳外资行动方案支持外资职业技能培训机构、基金投顾业务与风险管理工具。对目标行业仍带限制的外国公司,操作性问题在于适用哪个试点、牌照流程如何运转。本文梳理 2026 年分行业开放版图。

医疗:医院与药械通道

《国民健康”十五五”规划》(国发〔2026〕23 号)部署推动医疗领域有序扩大开放、进一步扩大外商独资医院开放试点、稳妥推进国际医疗服务试点。医院试点已覆盖北京、上海、天津、南京、苏州、福州、广东、深圳及海南全岛。外资医院集团加速落地:鹏瑞利国际医院、福州星耀眼科医院、南京韩美维媞整形医院被作为外资医院进入市场的案例提及。规划还支持优化创新药和临床急需药品审评审批、商业健康保险覆盖创新药械、人工智能赋能医药全产业链。对外资药械企业,规划在供给侧开放医院股权的同时,提供需求侧对创新产品的持续支持信号。

电信:增值电信试点规模化

增值电信开放试点于 2024 年 10 月在北京(服务业扩大开放综合示范区)、上海自贸试验区临港新片区及社会主义现代化建设引领区、海南自由贸易港、深圳中国特色社会主义先行示范区启动,取消互联网数据中心(IDC)、内容分发网络(CDN)、互联网接入服务(ISP)、在线数据处理与交易处理、信息发布平台服务等指定增值业务的外资股比限制。自 2025 年 2 月首批批复以来,已有 166 家外资企业获试点批复,部分全外资企业取得 IDC 资质——这对 AI 数据中心投资具有参照价值。全国外商投资电信企业超 3100 家,经营范围覆盖《电信业务分类目录》全部 10 项增值电信业务。稳外资行动方案支持继续推进并扩大试点。

教育与金融

教育开放依托服务业扩大开放综合试点(2025 年新增 9 个城市)与行动方案关于稳步扩大职业技能培训机构、职业院校、高水平理工农医类大学开放试点的承诺推进。金融端,行动方案支持更多外资机构运用包括国债期货在内的风险管理工具、外资机构依法开展基金投资顾问业务、优化重点外资企业跨境业务管理。这些对外资金融机构与教育集团评估进入都直接相关。

试点如何实际运转

各试点遵循同一形态:国家政策文件点名行业与试点区域;主管部委(医院为卫生健康部门与商务部、电信为工信部、教育为教育部)发布实施细则;省级部门处理申请;外资企业申办行业牌照或批复。医院由省卫健委与商务部门联合审查设立;增值电信由工信部核发试点批复、企业再就地申领增值电信业务许可证(ICP/EDI);教育由教育部审批合作或独立机构。时序不同:医院设立审查可能长达数月;电信批复分批发放;教育审批跟随教育部周期性批次。

实操步骤

其一,核验目标行业当前限制级别:全面开放、试点开放、有条件开放还是禁止。其二,适用试点的,确认试点区域覆盖计划地点且业务线在试点业务范围内。其三,准备行业申请材料:医院为可行性研究、外资医院集团资质、合作或独立设立方案;电信为企业架构证明股比合规与安全评估材料;教育为伙伴资质与课程方案。其四,尽早对接省商务部门一站式窗口与主管部委的预沟通渠道。其五,紧盯试点扩容公告——医院、生物技术、电信扩容明确在推进之列。

合规提示

行业试点并未消除全部限制:试点之外领域仍适用负面清单限制,每张牌照都附带条件(如业务范围、外资股比、电信安全审查)。《国民健康”十五五”规划》是规划性文件,医院与国际医疗试点的实施细则将由主管机关后续出台。外资投资者不应假设一地的试点扩展至其他地区,投入前应确认现行区域范围。

Sources

Sector Restrictions After Manufacturing Zeroing: Where Foreign Capital Can (and Cannot) Go in 2026

  • China’s unified Market Access Negative List (2025 edition) was cut to 106 items, down from 117 in 2022, while the foreign-investment access list stands at 29 national items with manufacturing fully zeroed.
    中国统一市场准入负面清单(2025版)由2022版117项减至106项,外资准入负面清单全国版保留29项、制造业全面清零。
  • The 2026 policy emphasis has shifted from manufacturing to services: telecom, internet, education, culture and healthcare are the next opening fronts.
    2026年政策重点由制造业转向服务业:电信、互联网、教育、文化、医疗成为下一开放重点。
  • The “Stabilise and Improve Foreign Investment” action plan (Shang Zi Fa [2026] No. 97) anchors services opening — vocational training, finance, pharmaceuticals — and the move from “access” to “operation.”
    《利用外资固稳促优行动方案》(商资发〔2026〕97号)锚定服务业开放——职业培训、金融、医药——并从”准入”转向”准营”。
  • A cross-border services negative list and pilot zones (telecom, biotech, wholly-foreign-owned hospitals) are the operational channels for new openings.
    跨境服务贸易负面清单与试点区域(电信、生物技术、外商独资医院)是新开放的操作通道。
  • Sector restrictions live in two lists: the market-access list (binds all entities) and the foreign-investment list (adds foreign-capital limits) — screen both.
    行业限制存在于两张清单:市场准入清单(约束所有主体)与外资准入清单(叠加外资限制)——须双查。
  • Practical step: map the target sector against both lists, use pilot zones for services openings, and track the 2026 action plan’s rollout.
    实操建议:将目标行业对照两张清单,服务业开放走试点区,并跟踪2026年行动方案落地。

Sector Restrictions After Manufacturing Zeroing: Where Foreign Capital Can (and Cannot) Go in 2026 | 制造业清零后的行业限制:2026年外资可进与禁区

China’s foreign-investment access regime now rests on a clear pivot: manufacturing restrictions are fully zeroed, and the policy centre of gravity has moved to services. For a foreign investor, the practical question is no longer “is manufacturing open?” but “which services sectors, through which channels, and under what pilots?” This article maps the current sector-restriction landscape.

The two-list architecture

Two parallel negative lists govern access:

  1. Market Access Negative List (市场准入负面清单) — binds every business form equally inside China. The 2025 edition (NDRC, MOFCOM, SAMR; Fa Gai Ti Gai Gui [2025] No. 466, issued 24 April 2025) cut items from 117 (2022) to 106, with national sub-measures falling from 486 to 469 and local measures from 36 to 20.
  2. Foreign Investment Access Negative List (外商投资准入负面清单) — adds foreign-capital-specific sector limits on top. As of 2026 it stands at 29 national items (27 in pilot free-trade zones). Critically, all manufacturing-sector restrictions are zeroed — the first industry fully liberalised.

The message of the 2025 market-access list is that items outside the list must be genuinely open; a barrier clean-up campaign publicly notifies typical cases and builds a rectification loop to remove “glass doors” beyond the list.

Manufacturing zeroed, services next

At a March 2026 State Council briefing, NDRC confirmed the foreign-investment list at 29 national / 27 FTZ items and signalled that the next phase focuses on services — telecom, internet, education, culture and healthcare to be opened “orderly.” The *15th Five-Year Plan* outline reinforces this: with the manufacturing access cleared, the focus is “expanding market access and opening in services.”

The 2026 action plan: services in detail

The *Action Plan for Stabilising and Improving Foreign Investment* (Shang Zi Fa [2026] No. 97) turns the services priority into concrete measures:

  • Deepening services opening: steadily expand pilot opening of vocational-skill training institutions, vocational schools and high-level polytechnic/agricultural/medical universities; upgrade Beijing’s services-opening demonstration zone; broaden CEPA for Hong Kong and Macao.
  • Financial services: more foreign institutions using risk-management tools (including government-bond futures), foreign-institution fund-investment advisory, cross-border financing facilitation, and pre-communication for onshore listings.
  • Pharmaceuticals: drug segment-manufacturing rules, broader biotechnology and wholly-foreign-owned-hospital pilot zones, innovative-device insurance coverage.

A 22 June 2026 State Council Information Office briefing framed the plan as moving from “access” to “operation” — fixing the “big door open, small door closed” problem through services opening and national treatment.

Operational channels for new openings

New services openings proceed through defined channels:

  • Cross-border services negative list. MOFCOM is improving the cross-border services-trade negative-list management system and orderly expanding autonomous opening in telecom, internet, education, culture and healthcare; value-added telecom, biotech and wholly-foreign-owned-hospital pilots continue and broaden.
  • Pilot zones. Designated pilot free-trade zones and services-opening demonstration cities trial field-level data-export negative lists and sector openings; apply there rather than assuming nationwide access.
  • National treatment. The plan commits to equal application of pro-enterprise support policies to foreign firms (except where laws clearly provide otherwise or national security is involved), and fair-competition review in government procurement and bidding.

Practical steps

  1. Screen both lists. Confirm the sector is outside — or acceptably inside — both the market-access and foreign-investment negative lists.
  2. Use the pilot pathway. Telecom, medical, education and biotech openings run via pilot zones; pursue them there.
  3. Watch CEPA and Beijing. Hong Kong/Macao investors and Beijing demonstration-zone players get earlier access.
  4. Plan for operation, not just access. Post-entry, align with data-security, Anti-Monopoly and tax obligations early.
  5. Track the action plan rollout. The 2026 plan’s measures phase in; monitor which zones are designated and when approvals open.

制造业清零后的行业限制:2026年外资可进与禁区

中国外资准入制度现已明确转折:制造业限制全面清零,政策重心转向服务业。对外国投资者而言,实际问题不再是”制造业是否开放?”,而是”哪些服务业、经哪些通道、在何种试点下开放?”。本文勾勒当前行业限制格局。

双清单架构

两张并行负面清单治理准入:

  1. 市场准入负面清单——对中国境内各类经营主体一体适用。2025版(国家发展改革委、商务部、市场监管总局;发改体改规〔2025〕466号,2025年4月24日印发)由2022版117项减至106项,全国性措施由486条减至469条,地方性措施由36条减至20条。
  2. 外商投资准入负面清单——在其上叠加外资专项行业限制。截至2026年全国版保留29项(自贸试验区版27项)。关键突破:制造业领域限制全面清零——首个全面开放的产业。

2025版市场准入清单的信号是:清单之外必须真放开;准入壁垒清理行动公开通报典型案例,并建立整改闭环以清除清单之外的”玻璃门”。

制造业清零、服务业接棒

在2026年3月国务院政策吹风会上,国家发展改革委确认外资准入清单全国版29项、自贸试验区版27项,并预示下一阶段以服务业为重点,推动电信、互联网、教育、文化、医疗”有序”扩大开放。”十五五”规划纲要强化此点:制造业准入清除后,重点转向”扩大服务业市场准入和开放领域”。

2026年行动方案:服务业的细节

《利用外资固稳促优行动方案》(商资发〔2026〕97号)将服务业优先转为具体措施:

  • 深化服务业开放: 稳步扩大职业技能培训机构、职业院校、高水平理工农医类大学对外开放试点;提升北京服务业扩大开放综合示范区;拓宽对港澳CEPA。
  • 金融业: 更多外资机构利用含国债期货的风险管理工具、外资机构依法开展基金投资顾问业务、跨境融资便利化、上市申报前预沟通。
  • 医药: 药品分段生产细则、扩大生物技术与外商独资医院试点区域、创新药械纳入保险。

2026年6月22日国新办发布会将该方案定位于从”准入”转向”准营”——以服务业开放与国民待遇破解”大门开、小门不开”。

新开放的操作通道

新服务业开放经明确通道推进:

  • 跨境服务贸易负面清单。 商务部完善跨境服务贸易负面清单管理制度,有序扩大电信、互联网、教育、文化、医疗自主开放;增值电信、生物技术、外商独资医院试点持续扩围。
  • 试点区域。 指定自贸试验区与服务业开放示范城市试点字段级数据出境负面清单与行业开放;应在试点区申请,而非假设全国放开。
  • 国民待遇。 方案承诺涉企支持政策对外资企业平等适用(法律明确规定或涉国家安全者除外),并在政府采购与招投标中落实公平竞争审查。

实操步骤

  1. 双清单筛查。 确认行业处于两张清单的”之外”或”可承受之内”。
  2. 走试点路径。 电信、医疗、教育、生物技术开放经试点区推进;应在试点区申请。
  3. 关注CEPA与北京。 港澳投资者与北京示范区主体获更早准入。
  4. 谋准营非仅准入。 进入后尽早对齐数据安全、反垄断与税务义务。
  5. 跟踪方案落地。 2026年方案措施分批推出;关注哪些区域被指定、何时开放审批。

Practitioner Quick Reference

  • 106 vs 29: market-access list 106 items (2025); foreign-investment list 29 national, manufacturing zeroed.
    106对比29:市场准入清单106项(2025);外资清单全国29项,制造业清零。
  • Services are the front: telecom, internet, education, culture, healthcare open “orderly” post-manufacturing zeroing.
    服务业是前沿:制造业清零后电信、互联网、教育、文化、医疗”有序”开放。
  • Shang Zi Fa [2026] No. 97: the plan that operationalises services opening and “access to operation.”
    商资发〔2026〕97号:落地服务业开放、从准入到准营的方案。
  • Two channels: cross-border services negative list + pilot zones (telecom, biotech, WFOE hospitals).
    两条通道:跨境服务贸易负面清单加试点区(电信、生物技术、外商独资医院)。

Common Pitfalls

  • Assuming nationwide services access: pilot-zone openings are not automatic national licences.
    以为服务业全国放开:试点区开放非自动全国牌照。
  • Screening only one list: missing the foreign-investment-specific limit risks a blocked entry.
    只查一张清单:漏掉外资专项限制可能致准入受阻。
  • Stopping at access: “big door open, small door closed” is solved by operation readiness, not approval alone.
    止于准入:”大门开、小门不开”靠准营准备解决,非仅靠批文。

Sources

Manufacturing Fully Open to Foreign Investment

  • As of the 2024 negative list, manufacturing is fully open to foreign investment with no remaining restricted entries.
    自 2024 年版负面清单起,制造业全面向外资产开放,已无残留受限条目。
  • Foreign investors may wholly own manufacturing WFOEs in China without an equity cap or prior approval for access.
    外资可全资持有在华制造外商独资企业,无需股比上限或准入事前审批。
  • The opening was delivered by deleting the entire “manufacturing” category from the negative list, not by partial relaxation.
    开放是通过从负面清单中删除整个”制造业”类别实现的,而非部分放松。
  • What remains for a manufacturer is ordinary licensing — environmental, safety, product and operating permits — not foreign-access limits.
    制造企业仍需面对的是常规许可——环保、安全、产品与经营许可——而非外资准入限制。
  • Sensitive sub-items touching defense, rare earths or critical tech may still draw security review or export-control scrutiny.
    触及国防、稀土或关键技术的敏感子项仍可能招致安全审查或出口管制审视。
  • Free-trade zones add incentives (tax, bonded logistics) on top of the national full-access baseline for manufacturers.
    自贸区在全国全面开放基线之上,为制造企业提供激励(税收、保税物流等)。
  • 2026 is about executing manufacturing entry efficiently — site selection, licensing and supply-chain setup — not clearing an access cap.
    2026 年的重点在于高效执行制造进入——选址、许可与供应链搭建——而非清掉准入上限。

Manufacturing Fully Open to Foreign Investment | 制造业全面向外资开放

The headline: manufacturing is off the list

The single clearest fact for an industrial investor in 2026 is that manufacturing in China is fully open to foreign investment. The 2024 negative list (《外商投资准入特别管理措施(负面清单)(2024年版)》, effective 1 November 2024) deleted the entire “manufacturing” (制造业) category. For the first time, there is no manufacturing entry on the foreign-investment negative list. A foreign investor may establish or acquire a manufacturing business and hold 100% ownership without a foreign-equity cap and without a foreign-access prior approval.

This is the endpoint of a multi-year sequence. Earlier lists had already removed caps in automobiles, shipbuilding, aircraft, and power equipment; the 2024 list finished the job by clearing the category altogether. The practical meaning: if you make physical goods, the access question is, for almost all products, already answered in your favor.

What “fully open” does and does not mean

“Fully open” means no foreign-equity restriction and no negative-list access approval. It does not mean “no regulation.” A manufacturing foreign-invested enterprise (FIE) is still incorporated through the normal company-registration channel, still submits the foreign-investment information report, and still needs the ordinary licences any Chinese manufacturer needs. The access gate is gone; the operating gates are not.

Those operating gates include: business-licence scope, environmental impact approval or filing, work-safety permits, product-quality and compulsory-certification (CCC) where applicable, and sector-specific permits (e.g., for food, drugs, medical devices, chemicals). These apply to domestic and foreign firms alike. The disciplined manufacturer maps them early; they, not the negative list, are where timelines are won or lost.

The path from approval to filing

For a typical unrestricted manufacturing WFOE, the sequence in 2026 is straightforward: screen the sector (off the list), reserve the name, incorporate via SAMR / the local market-regulation bureau using the one-network channel, submit the initial foreign-investment information report, open bank and foreign-exchange accounts, and obtain the relevant operating permits. No commerce-department approval sits in the path. The only ex-ante state reviews that could apply are national security review (for control-acquiring deals in covered defense/important sectors) and SAMR merger control (for transactions above turnover thresholds) — ordinary greenfield manufacturing is generally outside both.

Sensitive manufacturing sub-items

Full access is the default, but a few manufacturing-adjacent situations still draw scrutiny:

  • Defense and dual-use: manufacturing tied to national defense or dual-use items may trigger security review or export-control and technology-transfer rules.
  • Rare earths and key resources: processing and separation tied to rare earths and certain critical materials retain conditions and strategic control.
  • Critical technology: transactions involving important data, core technology, or critical information infrastructure may draw cybersecurity and security review.

These are edges, not the main field. A standard consumer-goods, components, machinery or electronics manufacturer is unaffected. The investor should confirm only that its specific product does not fall into a sensitive corner before assuming full access.

Why this matters for supply-chain strategy

Full manufacturing access reshapes how foreign groups use China. A wholly owned plant can serve the domestic market, export, and integrate into a regional supply chain without a local joint-venture partner imposed by law. This supports several 2026 strategies:

  • Local-for-local: own the plant that serves Chinese customers, protecting process and brand control.
  • Export platform: use China as a cost-competitive, fully foreign-owned export base.
  • R&D plus manufacturing: co-locate a WFOE factory with an R&D entity, with no ownership cap on either.
  • FTZ upside: layer FTZ incentives (tax, bonded logistics, streamlined customs) on top of the national full-access baseline.

The removal of the cap is therefore not merely symbolic; it changes the feasible ownership and operating models.

Free-trade zones add a layer

Although manufacturing is open nationwide, FTZs still add value for manufacturers through incentives rather than access. Bonded logistics, streamlined customs (e.g., the two-step declaration and AEO facilitation), tax treatments, and integrated service counters can lower the cost and time of a manufacturing operation. For a foreign manufacturer, the access decision is settled; the location decision then weighs incentives, logistics and talent. Hainan Free Trade Port and leading FTZs are natural candidates where the product and supply chain fit.

A 2026 manufacturing-entry checklist

  1. Confirm the product is off the negative list — for manufacturing, this is the baseline assumption, but verify no sensitive sub-item applies.
  2. Choose ownership — a 100% WFOE is permissible; a joint venture is optional, not required.
  3. Incorporate via the one-network channel and submit the initial foreign-investment information report.
  4. Map operating permits — environmental, safety, CCC, and sector licences — and start them early.
  5. Screen security review and merger control only if acquiring control of a covered or large business.
  6. Evaluate FTZ/Hainan incentives for logistics, tax and customs benefits.
  7. Set up the supply chain — import/export, bonded options, and local sourcing — within the opened framework.

Manufacturing is the part of China market entry where the hardest question — “may I own it?” — already has a clear answer. The 2026 work is the softer but decisive work of execution: licensing, siting, and supply chain.


制造业全面向外资开放

核心结论:制造业已移出清单

2026 年工业投资者最清晰的事实是:中国制造业已全面向外资产开放。2024 年版负面清单(《外商投资准入特别管理措施(负面清单)(2024年版)》,2024 年 11 月 1 日施行)删除了整个”制造业”类别。这是首次,外资负面清单上已无制造业条目。外资可设立或收购制造企业并持有 100% 股权,既无外资股比上限,亦无外资准入事前审批。

这是多年序列的终点。更早的清单已取消汽车、船舶、飞机及电力设备的股比上限;2024 版通过清空整个类别完成收尾。其实际含义是:若你生产实物商品,对几乎所有产品,准入问题已朝有利于你的方向解决。

“全面开放”的含义与边界

“全面开放”意味着无外资股比限制、无负面清单准入审批。它不意味着”无监管”。制造类外商投资企业仍须经普通公司登记渠道设立,仍须报送外商投资信息报告,仍须取得任何中资制造商都需要的常规许可。准入关卡已去,经营关卡未去。

这些经营关卡包括:经营范围、环评审批或备案、安全生产许可、适用时的产品质量与强制性产品认证(CCC),以及行业特定许可(如食品、药品、医疗器械、化学品)。这些对内资外资企业一体适用。纪律严明的制造商尽早梳理它们;成败所在正是这些,而非负面清单。

从审批到备案的路径

对典型的不受限制造业外商独资企业,2026 年的序列直截了当:筛查行业(清单外)、名称预留、经市场监管局一网通办渠道设立、报送外商投资初始信息报告、开立银行与外汇账户、取得相关经营许可。路径中无商务部门审批。可能适用的唯一事前国家审查是国家安全审查(受覆盖国防/重要领域取得控制权的交易)与 SAMR 经营者集中(达营业额阈值的交易)——普通绿地制造一般均不在此列。

敏感的制造子项

全面开放是默认,但少数制造相邻情形仍受审视:

  • 国防与两用:关联国防或两用品的制造可能触发安全审查或出口管制与技术转让规则。
  • 稀土与关键资源:关联稀土及若干关键材料的加工与分离保留条件与战略管控。
  • 关键技术:涉及重要数据、核心技术或关键信息基础设施的交易可能招致网络安全与安全审查。

这些是边角,而非主战场。标准的消费品、零部件、机械或电子制造商不受影响。投资者仅需确认其具体产品不落入敏感角落,即可假定全面开放。

这对供应链战略的意义

制造全面开放重塑了外资集团运用中国的方式。全资工厂可服务国内市场、出口,并融入区域供应链,而无需法律强加的本地合资伙伴。这支撑若干 2026 战略:

  • 本地供本地:持有服务中国客户的工厂,保护工艺与品牌控制。
  • 出口平台:将中国作为成本竞争力强、全资持有的出口基地。
  • 研发加制造:将外商独资企业工厂与研发实体同址,二者均无持股上限。
  • 自贸区加成:在全国全面开放基线之上叠加自贸区激励(税收、保税物流、简化海关)。

取消上限因此不唯象征;它改变了可行的所有体与运营模型。

自贸区叠加一层

尽管制造业全国开放,自贸区仍通过激励而非准入为制造商增值。保税物流、简化海关(如两步申报与 AEO 便利)、税收处理及综合服务窗口,可降低制造运营的成本与时间。对外资制造商,准入决定已定;选址决定继而权衡激励、物流与人才。在产品与供应链契合时,海南自贸港与领先自贸区是自然候选。

2026 年制造进入清单

  1. 确认产品不在负面清单上:对制造业,这是基线假定,但仍须核实无敏感子项适用。
  2. 选择所有体:100% 外商独资被允许;合资可选,非必须。
  3. 经一网通办设立并报送外商投资初始信息报告。
  4. 梳理经营许可:环保、安全、CCC 及行业许可,尽早启动。
  5. 仅当取得受覆盖或大型企业控制权时,筛查安全审查与经营者集中。
  6. 评估自贸区/海南激励:物流、税收与海关收益。
  7. 在开放框架下搭建供应链:进出口、保税选项与本地采购。

制造业是中国市场进入中”我能否持有?”这一最难问题已有明答的部分。2026 年的工作,是许可、选址与供应链这些更软却更决定性的执行工作。

Sources